Adherent device with multiple physiological sensors

Description

BACKGROUND OF THE INVENTION

1. Field of the Invention

The present invention relates to patient monitoring and/or therapy. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent device, the system methods and devices described herein may be applicable to many applications in which physiological monitoring and/or therapy is used for extended periods, for example wireless physiological monitoring for extended periods.

Patients are often treated for diseases and/or conditions associated with a compromised status of the patient, for example a compromised physiologic status. In some instances, a patient may report symptoms that require diagnosis to determine the underlying cause. For example, a patient may report fainting or dizziness that requires diagnosis, in which long term monitoring of the patient can provide useful information as to the physiologic status of the patient. In some instances a patient may have suffered a heart attack and require care and/or monitoring after release from the hospital. One example of a device to provide long term monitoring of a patient is the Holter monitor, or ambulatory electrocardiography device.

In addition to measuring heart signals with electrocardiograms, known physiologic measurements include impedance measurements. For example, transthoracic impedance measurements can be used to measure hydration and respiration. Although transthoracic measurements can be useful, such measurements may use electrodes that are positioned across the midline of the patient, and may be somewhat uncomfortable and/or cumbersome for the patient to wear. In at least some instances, the electrodes that are held against the skin of the patient may become detached and/or dehydrated, such that the electrodes must be replaced, thereby making long term monitoring more difficult.

Work in relation to embodiments of the present invention suggests that known methods and apparatus for long term monitoring of patients may be less than ideal. In at least some instances, devices that are worn by the patient may be somewhat uncomfortable, which may lead to patients not wearing the devices and not complying with direction from the health care provider, such that data collected may be less than ideal.

Therefore, a need exists for improved patient monitoring. Ideally, such improved patient monitoring would avoid at least some of the short-comings of the present methods and devices.

2. Description of the Background Art

The following U.S. Patents and Publications may describe relevant background art: U.S. Pat. Nos. 3,170,459; 3,370,459; 3,805,769; 3,845,757; 3,972,329; 4,121,573; 4,141,366; 4,838,273; 4,955,381; 4,981,139; 5,080,099; 5,353,793; 5,511,553; 5,544,661; 5,558,638; 5,724,025; 5,772,586; 5,862,802; 6,047,203; 6,117,077; 6,129,744; 6,225,901; 6,385,473; 6,416,471; 6,454,707; 6,527,711; 6,527,729; 6,551,252; 6,595,927; 6,595,929; 6,605,038; 6,645,153; 6,795,722; 6,821,249; 6,980,851; 7,020,508; 7,054,679; 7,153,262; 2003/0092975; 2005/0113703; 2005/0131288; 2006/0010090; 2006/0031102; 2006/0089679; 2006/122474; 2006/0155183; 2006/0224051; 2006/0264730; 2007/0021678; and 2007/0038038.

BRIEF SUMMARY OF THE INVENTION

The present invention relates to patient monitoring. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent patch, the system methods and device described herein may be applicable to any application in which physiological monitoring and/or therapy is used for extended periods, for example wireless physiological monitoring for extended periods. In many embodiments, the adherent device comprises a breathable support, for example a breathable adherent patch, and breathable cover that can be used for extended periods with improved patient comfort. The breathable adherent patch, for example breathable tape, and breathable cover may be configured to stretch, for example to stretch together along two dimensions of the skin of the patient when the patch is adhered to the skin of the patient, such that patient comfort and the lifetime of the patch on the skin can be improved.

In a first aspect, embodiments of the present invention provide an adherent device to monitor a patient for an extended period. The device comprises a breathable tape. The breathable tape comprising a porous material with an adhesive coating to adhere the breathable tape to a skin of the patient. At least one electrode is affixed to the breathable tape and capable of electrically coupling to a skin of the patient. A printed circuit board is connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient. Electronic components are electrically connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient. At least one of a breathable cover or an electronics housing is disposed over the circuit board and electronic components and connected to at least one of the electronics components, the printed circuit board or the breathable tape.

In many embodiments, the printed circuit board is connected to the breathable tape with an intermediate connector, for example to provide strain relief and/or decouple motion of the tape from the printed circuit board so as to provide comfort for the patient.

In many embodiments, a gap extends between the breathable tape and the printed circuit board. The gap may extend between the breathable tape and printed circuit board for a distance from about 0.25 mm to about 4 mm to allow the tape to breath under the printed circuit board when the tape is adhered to the patient. The gap can allow the tape to adhered to the body to conform to the skin and not be restricted by structures supported with the tape, for example rigid structures such as the printed circuitry board.

In many embodiments, the breathable cover comprises a stretchable material. This stretchable material can allow the cover to move and/or stretch, for example with the breathable tape, in response to patient movement. In many embodiments, the stretchable material comprises at least one of polyester fabric, nylon or polyamide fabric and the stretchable material comprises from about 5 to 25% elastane fabric. The stretchable material may comprise at least about 100% elongation, for example an elastomeric material comprising at least about 400% elongation.

In many embodiments, the breathable cover comprises at least one of a water repellant outside coating to repel water or hydrophilic inside coating to wick moisture away from the skin of the patient. Although either coating can be effective to keep excess moisture from the gel over the electrodes and can remove moisture from the skin of the patient for comfort, for example through the breathable tape, both coatings may be used together. The breathable cover may comprise a fabric weight from about 100 to 200 grams per square meter.

In many embodiments, the device comprises a flexible connection structure to couple the electrodes to the printed circuit board so as to relieve strain between the electrodes and the printed circuit board. The printed circuit board may be adhered to the breathable tape at a central location and the breathable tape may be configured to stretch with the skin of the patient away from the central location. The flexible connection structure can support the printed circuit board with a gap between the printed circuit board and the breathable tape. The flexible connection structure may comprise at least one of shielded wires, non-shielded wires, a flexible printed circuit board, or polyester film with silver printing.

In many embodiments, the breathable tape comprises a flexible material and a thickness from about 0.005″ to about 0.010″. In specific embodiments, the breathable tape may comprise a backing, which comprises a polyester knit fabric and a thickness from about 0.005″ to about 0.010″.

In many embodiments, the breathable tape comprises an acrylate pressure sensitive adhesive on an under side of the tape, the adhesive having a thickness less than about 0.004″ to allow the tape to breath when the adhesive is applied to the patient.

In many embodiments, the adherent device comprises an electronics housing adhered to at least one of the electronics components or the printed circuit board, such that the electronics housing is disposed between the cover and electronics components. The electronics housing may comprise a waterproof encapsulant to protect the printed circuit board and the electronic components from moisture and/or mechanical forces.

In many embodiments, the adherent device comprises a gel cover positioned over the breathable tape to inhibit a flow of the gel through the breathable tape, and the printed circuit board is located over the gel cover such that the gel cover is disposed between the breathable tape and the printed circuit board. In specific embodiments, the gel cover may comprise at least one of a polyurethane film or polyurethane non-woven backing and an acrylate pressure sensitive adhesive. The gel cover may comprise a porosity of at least about 200 sec./100 cc/in²to protect the hydrogel from external moisture. An edge of the gel cover may extend from about 5 to about 15 mm beyond an edge of a gel over the at least one electrode. In specific embodiments, the breathable tape may comprise a knit polyester fabric backing and the gel cover comprises a polyurethane, film backing.

In some embodiments, the breathable tape may comprise a first porosity, and the gel cover may comprise a breathable tape with a second porosity, the second porosity less than the first porosity to inhibit flow of the gel through the breathable tape having the first porosity.

In many embodiments, the breathable tape, the adhesive coating, the at least one electrode and the gel are separable from the printed circuit board, the electronic components and the at least one of the breathable cover or electronics housing, such that the printed circuit board, the electronic components, and the at least one of the breathable cover or the electronics housing are reusable.

In many embodiments, the at least one electrode extends through at least one aperture in the breathable tape. At least one gel can be disposed over a contact surface of the at least one electrode to electrically connect the electrode to the skin.

In some embodiments, the at least one electrode can be configured to electrically couple to the printed circuit board through the breathable tape.

In many embodiments, an adhesive can be disposed around the breathable tape to connect the cover to the breathable tape.

In many embodiments, the breathable tape comprises an MVTR of at least about 400 g/m²/24 hrs. The adherent device may further comprise a gel cover positioned over the breathable tape and an MVTR through the breathable tape and the gel cover comprises at least about 400 g/m²/24 hrs. An MVTR through the breathable tape, the gel cover and the breathable cover may comprise at least about 400 g/m²/24 hrs.

In another aspect, embodiments of the present invention provide an adherent device to monitor and/or treat a patient. A breathable support comprises a porous material with an adhesive coating to adhere the breathable support to a skin of the patient. A breathable cover is disposed over the breathable support. At least one of the cover or the breathable support is configured to stretch with the skin of the patient.

In many embodiments, the breathable cover is configured to stretch with the breathable support.

In many embodiments, the breathable support comprises a breathable tape.

In another aspect, embodiments of the present invention provide an adherent device to monitor and/or treat a patient, The device comprises a means for adhering to the patient and a means for covering.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1A shows a patient and a monitoring system comprising an adherent device, according to embodiments of the present invention;

FIG. 1B shows a bottom view of the adherent device as in FIG. 1A comprising an adherent patch;

FIG. 1C shows a top view of the adherent patch, as in FIG. 1B;

FIG. 1D shows a printed circuit boards and electronic components over the adherent patch, as in FIG. 1C;

FIG. 1D1 shows an equivalent circuit that can be used to determine optimal frequencies for determining patient hydration, according to embodiments of the present invention;

FIG. 1E shows batteries positioned over the printed circuit board and electronic components as in FIG. 1D;

FIG. 1F shows a top view of an electronics housing and a breathable cover over the batteries, electronic components and printed circuit board as in FIG. 1E;

FIG. 1G shows a side view of the adherent device as in FIGS. 1A to 1F;

FIG. 1H shown a bottom isometric view of the adherent device as in FIGS. 1A to 1G;

FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, of the adherent device as in FIGS. 1A to 1H;

FIGS. 1I1 and 1J1 show a side cross-sectional view and an exploded view, respectively, of an adherent device with a temperature sensor affixed to the gel cover, according to embodiments of the present invention;

FIG. 1K shows at least one electrode configured to electrically couple to a skin of the patient through a breathable tape, according to embodiments of the present invention; and

FIGS. 2A and 2B show components of an adherent device comprising an adhesive patch and connection structures to provide strain relief so as to decouple the adhesive patch from an electronics module, according to embodiments of the present invention.

DETAILED DESCRIPTION OF THE INVENTION

Embodiments of the present invention relate to patient monitoring and/or therapy. Although embodiments make specific reference to monitoring impedance and electrocardiogram signals with an adherent device, the system methods and device described herein may be applicable to any application in which physiological monitoring and/or therapy is used for extended periods, for example wireless physiological monitoring for extended periods.

The adherent device comprises a support, for example a patch that may comprise breathable tape, and the support can be configured to adhere to the patient and support the electronics and sensors on the patient. The support can be porous and breathable so as to allow water vapor transmission. The support can also stretch with skin of the patient, so as to improve patient comfort and extend the time that the support can be adhered to the patient.

In many embodiments, the adherent devices described herein may be used for 90 day monitoring, or more, and may comprise completely disposable components and/or reusable components, and can provide reliable data acquisition and transfer. In many embodiments, the patch is configured for patient comfort, such that the patch can be worn and/or tolerated by the patient for extended periods, for example 90 days or more. The patch may be worn continuously for at least seven days, for example 14 days, and then replaced with another patch. Adherent devices with comfortable patches that can be worn for extended periods and in which patches can be replaced and the electronics modules reused are described in U.S. Pat. App. Nos. 60/972,537, entitled “Adherent Device with Multiple Physiological Sensors”; and 60/972,629, entitled “Adherent Device with Multiple Physiological Sensors”, both filed on Sep. 14, 2007, the full disclosures of which have been previously incorporated herein by reference. In many embodiments, the adherent patch comprises a tape, which comprises a material, preferably breathable, with an adhesive, such that trauma to the patient skin can be minimized while the patch is worn for the extended period. The printed circuit board may comprise a flex printed circuit board that can flex with the patient to provide improved patient comfort.

FIG. 1A shows a patient P and a monitoring system 10. Patient P comprises a midline M, a first side S1, for example a right side, and a second side S2, for example a left side. Monitoring system 10 comprises an adherent device 100. Adherent device 100 can be adhered to a patient P at many locations, for example thorax T of patient P. In many embodiments, the adherent device may adhere to one side of the patient, from which side data can be collected. Work in relation with embodiments of the present invention suggests that location on a side of the patient can provide comfort for the patient while the device is adhered to the patient.

Monitoring system 10 includes components to transmit data to a remote center 106. Remote center 106 can be located in a different building from the patient, for example in the same town as the patient, and can be located as far from the patient as a separate continent from the patient, for example the patient located on a first continent and the remote center located on a second continent. Adherent device 100 can communicate wirelessly to an intermediate device 102, for example with a single wireless hop from the adherent device on the patient to the intermediate device. Intermediate device 102 can communicate with remote center 106 in many ways, for example with an internet connection and/or with a cellular connection. In many embodiments, monitoring system 10 comprises a distributed processing system with at least one processor comprising a tangible medium on device 100, at least one processor on intermediate device 102, and at least one processor 106P at remote center 106, each of which processors can be in electronic communication with the other processors. At least one processor 102P comprises a tangible medium 102T, and at least one processor 106P comprises a tangible medium 106T. Remote processor 106P may comprise a backend server located at the remote center. Remote center 106 can be in communication with a health care provider 108A with a communication system 107A, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Health care provider 108A, for example a family member, can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109A, for example by cell phone, email, landline. Remote center 106 can be in communication with a health care professional, for example a physician 108B, with a communication system 107B, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Physician 108B can be in communication with patient P with a communication, for example with a two way communication system, as indicated by arrow 109B, for example by cell phone, email, landline. Remote center 106 can be in communication with an emergency responder 108C, for example a 911 operator and/or paramedic, with a communication system 107C, such as the Internet, an intranet, phone lines, wireless and/or satellite phone. Emergency responder 108C can travel to the patient as indicated by arrow 109C. Thus, in many embodiments, monitoring system 10 comprises a closed loop system in which patient care can be monitored and implemented from the remote center in response to signals from the adherent device.

In many embodiments, the adherent device may continuously monitor physiological parameters, communicate wirelessly with a remote center, and provide alerts when necessary. The system may comprise an adherent patch, which attaches to the patient's thorax and contains sensing electrodes, battery, memory, logic, and wireless communication capabilities. In some embodiments, the patch can communicate with the remote center, via the intermediate device in the patient's home. In some embodiments, the remote center 106 receives the patient data and applies a patient evaluation and/or prediction algorithm. When a flag is raised, the center may communicate with the patient, hospital, nurse, and/or physician to allow for therapeutic intervention, for example to prevent decompensation.

The adherent device may be affixed and/or adhered to the body in many ways. For example, with at least one of the following an adhesive tape, a constant-force spring, suspenders around shoulders, a screw-in microneedle electrode, a pre-shaped electronics module to shape fabric to a thorax, a pinch onto roll of skin, or transcutaneous anchoring. Patch and/or device replacement may occur with a keyed patch (e.g. two-part patch), an outline or anatomical mark, a low-adhesive guide (place guide|remove old patch|place new patch|remove guide), or a keyed attachment for chatter reduction. The patch and/or device may comprise an adhesiveless embodiment (e.g. chest strap), and/or a low-irritation adhesive for sensitive skin. The adherent patch and/or device can comprise many shapes, for example at least one of a dogbone, an hourglass, an oblong, a circular or an oval shape.

In many embodiments, the adherent device may comprise a reusable electronics module with replaceable patches, and each of the replaceable patches may include a battery. The module may collect cumulative data for approximately 90 days and/or the entire adherent component (electronics+patch) may be disposable. In a completely disposable embodiment, a “baton” mechanism may be used for data transfer and retention, for example baton transfer may include baseline information. In some embodiments, the device may have a rechargeable module, and may use dual battery and/or electronics modules, wherein one module 101A can be recharged using a charging station 103 while the other module 101B is placed on the adherent patch with connectors. In some embodiments, the intermediate device 102 may comprise the charging module, data transfer, storage and/or transmission, such that one of the electronics modules can be placed in the intermediate device for charging and/or data transfer while the other electronics module is worn by the patient.

System 10 can perform the following functions: initiation, programming, measuring, storing, analyzing, communicating, predicting, and displaying. The adherent device may contain a subset of the following physiological sensors: bioimpedance, respiration, respiration rate variability, heart rate (ave, min, max), heart rhythm, hear rate variability (hereinafter “HRV”), heart rate turbulence (hereinafter “HRT”), heart sounds (e.g. S3), respiratory sounds, blood pressure, activity, posture, wake/sleep, orthopnea, temperature/heat flux, and weight. The activity sensor may comprise one or more of the following: ball switch, accelerometer, minute ventilation, HR, bioimpedance noise, skin temperature/heat flux, BP, muscle noise, posture.

The adherent device can wirelessly communicate with remote center 106. The communication may occur directly (via a cellular or Wi-Fi network), or indirectly through intermediate device 102. Intermediate device 102 may consist of multiple devices, which can communicate wired or wirelessly to relay data to remote center 106.

In many embodiments, instructions are transmitted from remote site 106 to a processor supported with the adherent patch on the patient, and the processor supported with the patient can receive updated instructions for the patient treatment and/or monitoring, for example while worn by the patient.

FIG. 1B shows a bottom view of adherent device 100 as in FIG. 1A comprising an adherent patch 110. Adherent patch 110 comprises a first side, or a lower side 110A, that is oriented toward the skin of the patient when placed on the patient. In many embodiments, adherent patch 110 comprises a tape 110T which is a material, preferably breathable, with an adhesive 116A. Patient side 110A comprises adhesive 116A to adhere the patch 110 and adherent device 100 to patient P. Electrodes 112A, 112B, 112C and 112D are affixed to adherent patch 110. In many embodiments, at least four electrodes are attached to the patch, for example six electrodes. In some embodiments the patch comprises two electrodes, for example two electrodes to measure the electrocardiogram (ECG) of the patient. Gel 114A, gel 114B, gel 114C and gel 114D can each be positioned over electrodes 112A, 112B, 112C and 112D, respectively, to provide electrical conductivity between the electrodes and the skin of the patient. In many embodiments, the electrodes can be affixed to the patch 110, for example with known methods and structures such as rivets, adhesive, stitches, etc. In many embodiments, patch 110 comprises a breathable material to permit air and/or vapor to flow to and from the surface of the skin.

FIG. 1C shows a top view of the adherent patch 100, as in FIG. 1B. Adherent patch 100 comprises a second side, or upper side 110B. In many embodiments, electrodes 112A, 112B, 112C and 112D extend from lower side 110A through adherent patch 110 to upper side 110B. An adhesive 116B can be applied to upper side 110B to adhere structures, for example a breathable cover, to the patch such that the patch can support the electronics and other structures when the patch is adhered to the patient. The printed circuit board (hereinafter “PCB”) may comprise completely flex PCB, combined flex PCB and/or rigid PCB boards connected by cable.

FIG. 1D shows a printed circuit boards and electronic components over adherent patch 110, as in FIGS. 1A to 1C. In some embodiments, a printed circuit board (PCB), for example flex printed circuit board 120, may be connected to electrodes 112A, 112B, 112C and 112D with connectors 122A, 122B, 122C and 122D. Flex printed circuit board 120 can include traces 123A, 123B, 123C and 123D that extend to connectors 122A, 122B, 122C and 122D, respectively, on the flex printed circuit board. Connectors 122A, 122B, 122C and 122D can be positioned on flex printed circuit board 120 in alignment with electrodes 112A, 112B, 112C and 112D so as to electrically couple the flex PCB with the electrodes. In some embodiments, connectors 122A, 122B, 122C and 122D may comprise insulated wires and/or a film with conductive ink that provide strain relief between the PCB and the electrodes. For example, connectors 122A, 122B, 122C and 122D may comprise a flexible film, such as at least one of known polyester film or known polyurethane film, coated with a conductive ink, for example a conductive silver ink. In some embodiments, additional PCB's, for example rigid PCB's 120A, 120B, 120C and 120D, can be connected to flex PCB 120. Electronic components 130 can be connected to flex PCB 120 and/or mounted thereon. In some embodiments, electronic components 130 can be mounted on the additional PCB's.

Electronic components 130 comprise components to take physiologic measurements, transmit data to remote center 106 and receive commands from remote center 106. In many embodiments, electronics components 130 may comprise known low power circuitry, for example complementary metal oxide semiconductor (CMOS) circuitry components. Electronics components 130 comprise an activity sensor and activity circuitry 134, impedance circuitry 136 and electrocardiogram circuitry, for example ECG circuitry 138. In some embodiments, electronics circuitry 130 may comprise a microphone and microphone circuitry 142 to detect an audio signal from within the patient, and the audio signal may comprise a heart sound and/or a respiratory sound, for example an S3 heart sound and a respiratory sound with rales and/or crackles.

Electronics circuitry 130 may comprise a temperature sensor 177, for example a thermistor in contact with the skin of the patient, and temperature sensor circuitry 144 to measure a temperature of the patient, for example a temperature of the skin of the patient. A temperature sensor 177 may be used to determine the sleep and wake state of the patient. The temperature of the patient can decrease as the patient goes to sleep and increase when the patient wakes up.

Work in relation to embodiments of the present invention suggests that skin temperature may effect impedance and/or hydration measurements, and that skin temperature measurements may be used to correct impedance and/or hydration measurements. In some embodiments, increase in skin temperature or heat flux can be associated with increased vasodilation near the skin surface, such that measured impedance measurement decreased, even through the hydration of the patient in deeper tissues under the skin remains substantially unchanged. Thus, use of the temperature sensor can allow for correction of the hydration signals to more accurately assess the hydration, for example extra cellular hydration, of deeper tissues of the patient, for example deeper tissues in the thorax.

Electronics circuitry 130 may comprise a processor 146. Processor 146 comprises a tangible medium, for example read only memory (ROM), electrically erasable programmable read only memory (EEPROM) and/or random access memory (RAM). Electronic circuitry 130 may comprise real time clock and frequency generator circuitry 148. In some embodiments, processor 136 may comprise the frequency generator and real time clock. The processor can be configured to control a collection and transmission of data from the impedance circuitry electrocardiogram circuitry and the accelerometer. In many embodiments, device 100 comprise a distributed processor system, for example with multiple processors on device 100.

In many embodiments, electronics components 130 comprise wireless communications circuitry 132 to communicate with remote center 106. Printed circuit board 120 may comprise an antenna to facilitate wireless communication. The antennae may be integral with printed circuit board 120 or may be separately coupled thereto. The wireless communication circuitry can be coupled to the impedance circuitry, the electrocardiogram circuitry and the accelerometer to transmit to a remote center with a communication protocol at least one of the hydration signal, the electrocardiogram signal or the inclination signal. In specific embodiments, wireless communication circuitry is configured to transmit the hydration signal, the electrocardiogram signal and the inclination signal to the remote center with a single wireless hop, for example from wireless communication circuitry 132 to intermediate device 102. The communication protocol comprises at least one of Bluetooth, Zigbee, WiFi, WiMax, IR, amplitude modulation or frequency modulation. In many embodiments, the communications protocol comprises a two way protocol such that the remote center is capable of issuing commands to control data collection.

Intermediate device 102 may comprise a data collection system to collect and store data from the wireless transmitter. The data collection system can be configured to communicate periodically with the remote center. The data collection system can transmit data in response to commands from remote center 106 and/or in response to commands from the adherent device.

Activity sensor and activity circuitry 134 can comprise many known activity sensors and circuitry. In many embodiments, the accelerometer comprises at least one of a piezoelectric accelerometer, capacitive accelerometer or electromechanical accelerometer. The accelerometer may comprises a 3-axis accelerometer to measure at least one of an inclination, a position, an orientation or acceleration of the patient in three dimensions. Work in relation to embodiments of the present invention suggests that three dimensional orientation of the patient and associated positions, for example sitting, standing, lying down, can be very useful when combined with data from other sensors, for example ECG data and/or hydration data.

Impedance circuitry 136 can generate both hydration data and respiration data. In many embodiments, impedance circuitry 136 is electrically connected to electrodes 112A, 112B, 112C and 112D such that electrodes 112A and 112D comprise outer electrodes that are driven with a current, or force electrodes. The current delivered between electrodes 112A and 112D generates a measurable voltage between electrodes 112B and 112C, such that electrodes 112B and 112C comprise inner sense electrodes that sense and/or measure the voltage in response to the current from the force electrodes. In some embodiments, electrodes 112B and 112C may comprise force electrodes and electrodes 112A and 112B may comprise sense electrodes. The voltage measured by the sense electrodes can be used measure the impedance of the patient to determine respiration rate and/or the hydration of the patient.

FIG. 1D1 shows an equivalent circuit 152 that can be used to determine optimal frequencies for measuring patient hydration. Work in relation to embodiments of the present invention indicates that the frequency of the current and/or voltage at the force electrodes can be selected so as to provide impedance signals related to the extracellular and/or intracellular hydration of the patient tissue. Equivalent circuit 152 comprises an intracellular resistance 156, or R(ICW) in series with a capacitor 154, and an extracellular resistance 158, or R(ECW). Extracellular resistance 158 is in parallel with intracellular resistance 156 and capacitor 154 related to capacitance of cell membranes. In many embodiments, impedances can be measured and provide useful information over a wide range of frequencies, for example from about 0.5 kHz to about 200 KHz. Work in relation to embodiments of the present invention suggests that extracellular resistance 158 can be significantly related extracellular fluid and to cardiac decompensation, and that extracellular resistance 158 and extracellular fluid can be effectively measured with frequencies in a range from about 0.5 kHz to about 20 kHz, for example from about 1 kHz to about 10 kHz. In some embodiments, a single frequency can be used to determine the extracellular resistance and/or fluid. As sample frequencies increase from about 10 kHz to about 20 kHz, capacitance related to cell membranes decrease the impedance, such that the intracellular fluid contributes to the impedance and/or hydration measurements. Thus, many embodiments of the present invention employ measure hydration with frequencies from about 0.5 kHz to about 20 kHz to determine patient hydration.

In many embodiments, impedance circuitry 136 can be configured to determine respiration of the patient. In specific embodiments, the impedance circuitry can measure the hydration at 25 Hz intervals, for example at 25 Hz intervals using impedance measurements with a frequency from about 0.5 kHz to about 20 kHz.

ECG circuitry 138 can generate electrocardiogram signals and data from two or more of electrodes 112A, 112B, 112C and 112D in many ways. In some embodiments, ECG circuitry 138 is connected to inner electrodes 112B and 122C, which may comprise sense electrodes of the impedance circuitry as described above. In some embodiments, ECG circuitry 138 can be connected to electrodes 112A and 112D so as to increase spacing of the electrodes. The inner electrodes may be positioned near the outer electrodes to increase the voltage of the ECG signal measured by ECG circuitry 138. In many embodiments, the ECG circuitry may measure the ECG signal from electrodes 112A and 112D when current is not passed through electrodes 112A and 112D, for example with switches as described in U.S. App. No. 60/972,527, the full disclosure of which has been previously incorporated herein by reference.

FIG. 1E shows batteries 150 positioned over the flex printed circuit board and electronic components as in FIG. 1D. Batteries 150 may comprise rechargeable batteries that can be removed and/or recharged. In some embodiments, batteries 150 can be removed from the adherent patch and recharged and/or replaced.

FIG. 1F shows a top view of a cover 162 over the batteries, electronic components and flex printed circuit board as in FIGS. 1A to 1E. In many embodiments, an electronics housing 160 may be disposed under cover 162 to protect the electronic components, and in some embodiments electronics housing 160 may comprise an encapsulant over the electronic components and PCB. In some embodiments, cover 162 can be adhered to adherent patch 110 with an adhesive 164 on an underside of cover 162. In many embodiments, electronics housing 160 may comprise a water proof material, for example a sealant adhesive such as epoxy or silicone coated over the electronics components and/or PCB. In some embodiments, electronics housing 160 may comprise metal and/or plastic. Metal or plastic may be potted with a material such as epoxy or silicone.

Cover 162 may comprise many known biocompatible cover, casing and/or housing materials, such as elastomers, for example silicone. The elastomer may be fenestrated to improve breathability. In some embodiments, cover 162 may comprise many known breathable materials, for example polyester, polyamide, nylon and/or elastane (Spandex™). The breathable fabric may be coated to make it water resistant, waterproof, and/or to aid in wicking moisture away from the patch.

FIG. 1G shows a side view of adherent device 100 as in FIGS. 1A to 1F. Adherent device 100 comprises a maximum dimension, for example a length 170 from about 4 to 10 inches (from about 100 mm to about 250 mm), for example from about 6 to 8 inches (from about 150 mm to about 200 mm). In some embodiments, length 170 may be no more than about 6 inches (no more than about 150 mm). Adherent device 100 comprises a thickness 172. Thickness 172 may comprise a maximum thickness along a profile of the device. Thickness 172 can be from about 0.2 inches to about 0.6 inches (from about 5 mm to about 15 mm), from about 0.2 inches to about 0.4 inches (from about 5 mm to about 10 mm), for example about 0.3 inches (about 7.5 mm).

FIG. 1H shown a bottom isometric view of adherent device 100 as in FIGS. 1A to 1G. Adherent device 100 comprises a width 174, for example a maximum width along a width profile of adherent device 100. Width 174 can be from about 2 to about 4 inches (from about 50 mm to 100 mm), for example about 3 inches (about 75 mm).

FIGS. 1I and 1J show a side cross-sectional view and an exploded view, respectively, of adherent device 100 as in FIGS. 1A to 1H. In many embodiments, device 100 comprises several layers.

FIGS. 1I1 and 1J1 show a side cross-sectional view and an exploded view, respectively, of embodiments of the adherent device with a temperature sensor affixed to the gel cover. In these embodiments, gel cover 180 extends over a wider area than in the embodiments shown in FIGS. 1I and 1J. Temperature sensor 177 is disposed over a peripheral portion of gel cover 180. Temperature sensor 177 can be affixed to gel cover 180 such that the temperature sensor can move when the gel cover stretches and tape stretch with the skin of the patient. Temperature sensor 177 may be coupled to temperature sensor circuitry 144 through a flex connection comprising at least one of wires, shielded wires, non-shielded wires, a flex circuit, or a flex PCB. This coupling of the temperature sensor allows the temperature near the skin to be measured though the breathable tape and the gel cover. The temperature sensor can be affixed to the breathable tape, for example through a cutout in the gel cover with the temperature sensor positioned away from the gel pads. A heat flux sensor can be positioned near the temperature sensor, for example to measure heat flux through to the gel cover, and the heat flux sensor coupled to heat flux circuitry similar to the temperature sensor.

The adherent device comprises electrodes 112A1, 112B1, 112C1 and 112D1 configured to couple to tissue through apertures in the breathable tape 110T. Electrodes 112A1, 112B1, 112C1 and 112D1 can be fabricated in many ways. For example, electrodes 112A1, 112B1, 112C1 and 112D1 can be printed on a flexible connector 112F, such as silver ink on polyurethane. Breathable tape 110T comprise apertures 180A1, 180B1, 180C1 and 180D1. Electrodes 112A1, 112B1, 112C1 and 112D1 are exposed to the gel through apertures 180A1, 180B1, 180C1 and 180D1 of breathable tape 110T. Gel 114A, gel 114B, gel 114C and gel 114D can be positioned over electrodes 112A1, 112B1, 112C1 and 112D1 and the respective portions of breathable tape 110T proximate apertures 180A1, 180B1, 180C1 and 180D1, so as to couple electrodes 112A1, 112B1, 112C1 and 112D1 to the skin of the patient. The flexible connector 112F comprising the electrodes can extend from under the gel cover to the printed circuit board to connect to the printed circuit boards and/or components supported thereon. For example, flexible connector 112F may comprise flexible connector 122A to provide strain relief, as described above.

In many embodiments, gel 114A, or gel layer, comprises a hydrogel that is positioned on electrode 112A to provide electrical conductivity between the electrode and the skin. In many embodiments, gel 114A comprises a hydrogel that provides a conductive interface between skin and electrode, so as to reduce impedance between electrode/skin interface. In many embodiments, gel may comprise water, glycerol, and electrolytes, pharmacological agents, such as beta blockers, ace inhibitors, diuretics, steroid for inflammation, antibiotic, antifungal agent. In specific embodiments the gel may comprise cortisone steroid. The gel layer may comprise many shapes, for example, square, circular, oblong, star shaped, many any polygon shapes. In specific embodiments, the gel layer may comprise at least one of a square or circular geometry with a dimension in a range from about 0.005″ to about 0.100″, for example within a range from about 0.015″-0.070″, in some embodiments within a range from about 0.015″-0.040″, and in specific embodiments within a range from about 0.020″-0.040″. In many embodiments, the gel layer of each electrode comprises an exposed surface area to contact the skin within a range from about 100 mm^2 to about 1500 mm^2, for example a range from about 250 mm^2 to about 750 mm^2, and in specific embodiments within a range from about 350 mm^2 to about 650 mm^2. Work in relation with embodiments of the present invention suggests that such dimensions and/or exposed surface areas can provide enough gel area for robust skin interface without excessive skin coverage. In many embodiments, the gel may comprise an adhesion to skin, as may be tested with a 1800 degree peel test on stainless steel, of at least about 3 oz/in, for example an adhesion within a range from about 5-10 oz/in. In many embodiments, a spacing between gels is at least about 5 mm, for example at least about 10 mm. Work in relation to embodiments of the present invention suggests that this spacing may inhibit the gels from running together so as to avoid crosstalk between the electrodes. In many embodiments, the gels comprise a water content within a range from about 20% to about 30%, a volume resistivity within a range from about 500 to 2000 ohm-cm, and a pH within a range from about 3 to about 5.

In many embodiments, the electrodes, for example electrodes 112A to 112D, may comprise an electrode layer. A 0.001″-0.005″ polyester strip with silver ink for traces can extend to silver/silver chloride electrode pads. In many embodiments, the electrodes can provide electrical conduction through hydrogel to skin, and in some embodiments may be coupled directly to the skin. Although at least 4 electrodes are shown, some embodiments comprise at least two electrodes, for example 2 electrodes. In some embodiments, the electrodes may comprise at least one of carbon-filled ABS plastic, silver, nickel, or electrically conductive acrylic tape. In specific embodiments, the electrodes may comprise at least one of carbon-filled ABS plastic, Ag/AgCl. The electrodes may comprise many geometric shapes to contact the skin, for example at least one of square, circular, oblong, star shaped, polygon shaped, or round. In specific embodiments, a dimension across a width of each electrodes is within a range from about 002″ to about 0.050″, for example from about 0.010 to about 0.040″. In many a surface area of the electrode toward the skin of the patient is within a range from about 25 mm^2 to about 1500 mm^2, for example from about 75 mm^2 to about 150 mm^2. In many embodiments, the electrode comprises a tape that may cover the gel near the skin of the patient. In specific embodiments, the two inside electrodes may comprise force, or current electrodes, with a center to center spacing within a range from about 20 to about 50 mm. In specific embodiments, the two outside electrodes may comprise measurement electrodes, for example voltage electrodes, and a center-center spacing between adjacent voltage and current electrodes is within a range from about 15 mm to about 35 mm. Therefore, in many embodiments, a spacing between inner electrodes may be greater than a spacing between an inner electrode and an outer electrode.

In many embodiments, adherent patch 110 may comprise a layer of breathable tape 110T, for example a known breathable tape, such as tricot-knit polyester fabric. In many embodiments, breathable tape 110T comprises a backing material, or backing 111, with an adhesive. In many embodiments, the patch adheres to the skin of the patient's body, and comprises a breathable material to allow moisture vapor and air to circulate to and from the skin of the patient through the tape. In many embodiments, the backing is conformable and/or flexible, such that the device and/or patch does not become detached with body movement. In many embodiments, backing can sufficiently regulate gel moisture in absence of gel cover. In many embodiments, adhesive patch may comprise from 1 to 2 pieces, for example 1 piece. In many embodiments, adherent patch 110 comprises pharmacological agents, such as at least one of beta blockers, ace inhibitors, diuretics, steroid for inflammation, antibiotic, or antifungal agent. In specific embodiments, patch 110 comprises cortisone steroid. Patch 110 may comprise many geometric shapes, for example at least one of oblong, oval, butterfly, dogbone, dumbbell, round, square with rounded corners, rectangular with rounded corners, or a polygon with rounded corners. In specific embodiments, a geometric shape of patch 110 comprises at least one of an oblong, an oval or round. In many embodiments, the geometric shape of the patch comprises a radius on each corner that is no less than about one half a width and/or diameter of tape. Work in relation to embodiments of the present invention suggests that rounding the corner can improve adherence of the patch to the skin for an extended period of time because sharp corners, for example right angle corners, can be easy to peel. In specific embodiments, a thickness of adherent patch 110 is within a range from about 0.001″ to about 0.020″, for example within a range from about 0.005″ to about 0.010″. Work in relation to embodiments of the present invention indicates that these ranges of patch thickness can improve adhesion of the device to the skin of the patient for extended periods as a thicker adhesive patch, for example tape, may peel more readily. In many embodiments, length 170 of the patch is within a range from about 2″ to about 10″, width 174 of the patch is within a range from about 1″ to about 5″. In specific embodiments, length 170 is within a range from about 4″ to about 8″ and width 174 is within a range from about 2″ to about 4″. In many embodiments, an adhesion to the skin, as measured with a 180 degree peel test on stainless steel, can be within a range from about 10 to about 100 oz/in width, for example within a range from about 30 to about 70 oz/in width. Work in relation to embodiments of the present invention suggests that adhesion within these ranges may improve the measurement capabilities of the patch because if the adhesion is too low, patch will not adhere to the skin of the patient for a sufficient period of time and if the adhesion is too high, the patch may cause skin irritation upon removal. In many embodiments adherent patch 110 comprises a moisture vapor transmission rate (MVTR, g/m^2/24 hrs) per American Standard for Testing and Materials E-96 (ASTM E-96) is at least about 400, for example at least about 1000. Work in relation to embodiments of the present invention suggest that MVTR values as specified above can provide improved comfort, for example such that in many embodiments skin does not itch. In some embodiments, the breathable tape 110T of adherent patch 110 may comprise a porosity (sec./100 cc/in²) within a wide range of values, for example within a range from about 0 to about 200. The porosity of breathable tape 11 OT may be within a range from about 0 to about 5. The above amounts of porosity can minimize itching of the patient's skin when the patch is positioned on the skin of the patient. In many embodiments, the MVTR values above may correspond to a MVTR through both the gel cover and the breathable tape. The above MVTR values may also correspond to an MVTR through the breathable tape, the gel cover and the breathable cover. The MVTR can be selected to minimize patient discomfort, for example itching of the patient's skin.

In some embodiments, the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.

In many embodiments, tape 110T of adherent patch 110 may comprise backing material, or backing 111, such as a fabric configured to provide properties of patch 110 as described above. In many embodiments backing 111 provides structure to breathable tape 110T, and many functional properties of breathable tape 11 OT as described above. In many embodiments, backing 111 comprises at least one of polyester, polyurethane, rayon, nylon, breathable plastic film; woven, nonwoven, spunlace, knit, film, or foam. In specific embodiments, backing 111 may comprise polyester tricot knit fabric. In many embodiments, backing 111 comprises a thickness within a range from about 0.0005″ to about 0.020″, for example within a range from about 0.005″ to about 0.010″.

In many embodiments, an adhesive 116A, for example breathable tape adhesive comprising a layer of acrylate pressure sensitive adhesive, can be disposed on underside 110A of patch 110. In many embodiments, adhesive 116A adheres adherent patch 110 comprising backing 111 to the skin of the patient, so as not to interfere with the functionality of breathable tape, for example water vapor transmission as described above. In many embodiments, adhesive 116A comprises at least one of acrylate, silicone, synthetic rubber, synthetic resin, hydrocolloid adhesive, pressure sensitive adhesive (PSA), or acrylate pressure sensitive adhesive. In many embodiments, adhesive 116A comprises a thickness from about 0.0005″ to about 0.005″, in specific embodiments no more than about 0.003″. Work in relation to embodiments of the present invention suggests that these thicknesses can allow the tape to breathe and/or transmit moisture, so as to provide patient comfort.

A gel cover 180, or gel cover layer, for example a polyurethane non-woven tape, can be positioned over patch 110 comprising the breathable tape. A PCB layer, for example flex printed circuit board 120, or flex PCB layer, can be positioned over gel cover 180 with electronic components 130 connected and/or mounted to flex printed circuit board 120, for example mounted on flex PCB so as to comprise an electronics layer disposed on the flex PCB layer. In many embodiments, the adherent device may comprise a segmented inner component, for example the PCB may be segmented to provide at least some flexibility. In many embodiments, the electronics layer may be encapsulated in electronics housing 160 which may comprise a waterproof material, for example silicone or epoxy. In many embodiments, the electrodes are connected to the PCB with a flex connection, for example trace 123A of flex printed circuit board 120, so as to provide strain relive between the electrodes 112A, 112B, 112C and 112D and the PCB.

Gel cover 180 can inhibit flow of gel 114A and liquid. In many embodiments, gel cover 180 can inhibit gel 114A from seeping through breathable tape 110T to maintain gel integrity over time. Gel cover 180 can also keep external moisture from penetrating into gel 114A. For example gel cover 180 can keep liquid water from penetrating though the gel cover into gel 114A, while allowing moisture vapor from the gel, for example moisture vapor from the skin, to transmit through the gel cover. The gel cover may comprise a porosity at least 200 sec./100 cc/in², and this porosity can ensure that there is a certain amount of protection from external moisture for the hydrogel.

In many embodiments, the gel cover can regulate moisture of the gel near the electrodes so as to keeps excessive moisture, for example from a patient shower, from penetrating gels near the electrodes. In many embodiments, the gel cover may avoid release of excessive moisture form the gel, for example toward the electronics and/or PCB modules. Gel cover 180 may comprise at least one of a polyurethane, polyethylene, polyolefin, rayon, PVC, silicone, non-woven material, foam, or a film. In many embodiments gel cover 180 may comprise an adhesive, for example a acrylate pressure sensitive adhesive, to adhere the gel cover to adherent patch 110. In specific embodiments gel cover 180 may comprise a polyurethane film with acrylate pressure sensitive adhesive. In many embodiments, a geometric shape of gel cover 180 comprises at least one of oblong, oval, butterfly, dogbone, dumbbell, round, square, rectangular with rounded corners, or polygonal with rounded corners. In specific embodiments, a geometric shape of gel cover 180 comprises at least one of oblong, oval, or round. In many embodiments, a thickness of gel cover is within a range from about 0.0005″ to about 0.020″, for example within a range from about 0.0005 to about 0.010″. In many embodiments, gel cover 180 can extend outward from about 0-20 mm from an edge of gels, for example from about 5-15 mm outward from an edge of the gels.

In many embodiments, the breathable tape of adherent patch 110 comprises a first mesh with a first porosity and gel cover 180 comprises a breathable tape with a second porosity, in which the second porosity is less than the first porosity to inhibit flow of the gel through the breathable tape.

In many embodiments, device 100 includes a printed circuitry, for example a printed circuitry board (PCB) module that includes at least one PCB with electronics component mounted thereon on and the battery, as described above. In many embodiments, the PCB module comprises two rigid PCB modules with associated components mounted therein, and the two rigid PCB modules are connected by flex circuit, for example a flex PCB. In specific embodiments, the PCB module comprises a known rigid FR4 type PCB and a flex PCB comprising known polyimide type PCB. In specific embodiments, the PCB module comprises a rigid PCB with flex interconnects to allow the device to flex with patient movement. The geometry of flex PCB module may comprise many shapes, for example at least one of oblong, oval, butterfly, dogbone, dumbbell, round, square, rectangular with rounded corners, or polygon with rounded corners. In specific embodiments the geometric shape of the flex PCB module comprises at least one of dogbone or dumbbell. The PCB module may comprise a PCB layer with flex PCB 120 can be positioned over gel cover 180 and electronic components 130 connected and/or mounted to flex PCB 120 so as to comprise an electronics layer disposed on the flex PCB. In many embodiments, the adherent device may comprise a segmented inner component, for example the PCB, for limited flexibility. The printed circuit may comprise polyester film with silver traces printed thereon.

In many embodiments, the electronics layer may be encapsulated in electronics housing 160. Electronics housing 160 may comprise an encapsulant, such as a dip coating, which may comprise a waterproof material, for example silicone and/or epoxy. In many embodiments, the PCB encapsulant protects the PCB and/or electronic components from moisture and/or mechanical forces. The encapsulant may comprise silicone, epoxy, other adhesives and/or sealants. In some embodiments, the electronics housing may comprising metal and/or plastic housing and potted with aforementioned sealants and/or adhesives.

In many embodiments, the electrodes are connected to the PCB with a flex connection, for example trace 123A of flex PCB 120, so as to provide strain relive between the electrodes 112A, 112B, 112C and 112D and the PCB. In such embodiments, motion of the electrodes relative to the electronics modules, for example rigid PCB's 120A, 120B, 120C and 120D with the electronic components mounted thereon, does not compromise integrity of the electrode/hydrogel/skin contact. In some embodiments, the electrodes can be connected to the PCB and/or electronics module with a flex PCB 120, such that the electrodes and adherent patch can move independently from the PCB module. In many embodiments, the flex connection comprises at least one of wires, shielded wires, non-shielded wires, a flex circuit, or a flex PCB. In specific embodiments, the flex connection may comprise insulated, non-shielded wires with loops to allow independent motion of the PCB module relative to the electrodes.

In many embodiments, cover 162 can encase the flex PCB and/or electronics and can be adhered to at least one of the electronics, the flex PCB or adherent patch 110, so as to protect at least the electronics components and the PCB. Cover 162 can attach to adherent patch 110 with adhesive 116B. Cover 162 can comprise many known biocompatible cover materials, for example silicone. Cover 162 can comprise an outer polymer cover to provide smooth contour without limiting flexibility. In many embodiments, cover 162 may comprise a breathable fabric. Cover 162 may comprise many known breathable fabrics, for example breathable fabrics as described above. In some embodiments, the breathable cover may comprise a breathable water resistant cover. In some embodiments, the breathable fabric may comprise polyester, nylon, polyamide, and/or elastane (Spandex™) to allow the breathable fabric to stretch with body movement. In some embodiments, the breathable tape may contain and elute a pharmaceutical agent, such as an antibiotic, anti-inflammatory or antifungal agent, when the adherent device is placed on the patient.

In specific embodiments, cover 162 comprises at least one of polyester, 5-25% elastane/spandex, polyamide fabric; silicone, a polyester knit, a polyester knit without elastane, or a thermoplastic elastomer. In many embodiments cover 162 comprises at least 400% elongation. In specific embodiments, cover 162 comprises at least one of a polyester knit with 10-20% spandex or a woven polyamide with 10-20% spandex. In many embodiments, cover 162 comprises a water repellent coating and/or layer on outside, for example a hydrophobic coating, and a hydrophilic coating on inside to wick moisture from body. In many embodiments the water repellent coating on the outside comprises a stain resistant coating. Work in relation to embodiments of the present invention suggests that these coatings can be important to keep excessive moisture from the gels near the electrodes and to remove moisture from body so as to provide patient comfort.

The breathable cover 162 and adherent patch 110 comprise breathable tape can be configured to couple continuously for at least one week the at least one electrode to the skin so as to measure breathing of the patient. The breathable tape may comprise the stretchable breathable material with the adhesive and the breathable cover may comprises a stretchable breathable material connected to the breathable tape, as described above, such that both the adherent patch and cover can stretch with the skin of the patient. The breathable cover may also comprise a water resistant material. Arrows 182 show stretching of adherent patch 110, and the stretching of adherent patch can be at least two dimensional along the surface of the skin of the patient. As noted above, connectors 122A, 122B, 122C and 122D between PCB 130 and electrodes 112A, 112B, 112C and 112D may comprise insulated wires that provide strain relief between the PCB and the electrodes, such that the electrodes can move with the adherent patch as the adherent patch comprising breathable tape stretches. Arrows 184 show stretching of cover 162, and the stretching of the cover can be at least two dimensional along the surface of the skin of the patient.

Cover 162 can be attached to adherent patch 110 with adhesive 116B such that cover 162 stretches and/or retracts when adherent patch 110 stretches and/or retracts with the skin of the patient. For example, cover 162 and adherent patch 110 can stretch in two dimensions along length 170 and width 174 with the skin of the patient, and stretching along length 170 can increase spacing between electrodes. Stretching of the cover and adherent patch 110, for example in two dimensions, can extend the time the patch is adhered to the skin as the patch can move with the skin such that the patch remains adhered to the skin. Electronics housing 160 can be smooth and allow breathable cover 162 to slide over electronics housing 160, such that motion and/or stretching of cover 162 is slidably coupled with housing 160. The printed circuit board can be slidably coupled with adherent patch 110 that comprises breathable tape 110T, such that the breathable tape can stretch with the skin of the patient when the breathable tape is adhered to the skin of the patient, for example along two dimensions comprising length 170 and width 174.

The stretching of the adherent device 100 along length 170 and width 174 can be characterized with a composite modulus of elasticity determined by stretching of cover 162, adherent patch 110 comprising breathable tape 110T and gel cover 180. For the composite modulus of the composite fabric cover-breathable tape-gel cover structure that surrounds the electronics, the composite modulus may comprise no more than about 1 MPa, for example no more than about 0.3 MPa at strain of no more than about 5%. These values apply to any transverse direction against the skin.

The stretching of the adherent device 100 along length 170 and width 174, may also be described with a composite stretching elongation of cover 162, adherent patch 110 comprising breathable tape breathable tape 110T and gel cover 180. The composite stretching elongation may comprise a percentage of at least about 10% when 3 kg load is a applied, for example at least about 100% when the 3 kg load applied. These percentages apply to any transverse direction against the skin.

The printed circuit board may be adhered to the adherent patch 110 comprising breathable tape 110T at a central portion, for example a single central location, such that adherent patch 110 can stretch around this central region. The central portion can be sized such that the adherence of the printed circuit board to the breathable tape does not have a substantial effect of the modulus of the composite modulus for the fabric cover, breathable tape and gel cover, as described above. For example, the central portion adhered to the patch may be less than about 100 mm², for example with dimensions of approximately 10 mm by 10 mm (about 0.5″ by 0.5″). Such a central region may comprise no more than about 10% of the area of patch 110, such that patch 110 can stretch with the skin of the patient along length 170 and width 174 when the patch is adhered to the patient.

The cover material may comprise a material with a low recovery, which can minimize retraction of the breathable tape from the pulling by the cover. Suitable cover materials with a low recovery include at least one of polyester or nylon, for example polyester or nylon with a loose knit. The recovery of the cover material may be within a range from about 0% recovery to about 25% recovery. Recovery can refer to the percentage of retraction the cover material that occurs after the material has been stretched from a first length to a second length. For example, with 25% recovery, a cover that is stretched from a 4 inch length to a 5 inch length will retract by 25% to a final length of 4.75 inches.

Electronics components 130 can be affixed to printed circuit board 120, for example with solder, and the electronics housing can be affixed over the PCB and electronics components, for example with dip coating, such that electronics components 130, printed circuit board 120 and electronics housing 160 are coupled together. Electronics components 130, printed circuit board 120, and electronics housing 160 are disposed between the stretchable breathable material of adherent patch 110 and the stretchable breathable material of cover 160 so as to allow the adherent patch 110 and cover 160 to stretch together while electronics components 130, printed circuit board 120, and electronics housing 160 do not stretch substantially, if at all. This decoupling of electronics housing 160, printed circuit board 120 and electronic components 130 can allow the adherent patch 110 comprising breathable tape to move with the skin of the patient, such that the adherent patch can remain adhered to the skin for an extended time of at least one week, for example two or more weeks.

An air gap 169 may extend from adherent patch 110 to the electronics module and/or PCB, so as to provide patient comfort. Air gap 169 allows adherent patch 110 and breathable tape 110T to remain supple and move, for example bend, with the skin of the patient with minimal flexing and/or bending of printed circuit board 120 and electronic components 130, as indicated by arrows 186. Printed circuit board 120 and electronics components 130 that are separated from the breathable tape 110T with air gap 169 can allow the skin to release moisture as water vapor through the breathable tape, gel cover, and breathable cover. This release of moisture from the skin through the air gap can minimize, and even avoid, excess moisture, for example when the patient sweats and/or showers.

The breathable tape of adherent patch 110 may comprise a first mesh with a first porosity and gel cover 180 may comprise a breathable tape with a second porosity, in which the second porosity is less than the first porosity to minimize, and even inhibit, flow of the gel through the breathable tape. The gel cover may comprise a polyurethane film with the second porosity.

Cover 162 may comprise many shapes. In many embodiments, a geometry of cover 162 comprises at least one of oblong, oval, butterfly, dogbone, dumbbell, round, square, rectangular with rounded corners, or polygonal with rounded corners. In specific embodiments, the geometric of cover 162 comprises at least one of an oblong, an oval or a round shape.

Cover 162 may comprise many thicknesses and/or weights. In many embodiments, cover 162 comprises a fabric weight: within a range from about 100 to about 200 g/m^2, for example a fabric weight within a range from about 130 to about 170 g/m^2.

In many embodiments, cover 162 can attach the PCB module to adherent patch 110 with cover 162, so as to avoid interaction of adherent patch 110C with the PCB having the electronics mounted therein. Cover 162 can be attached to breathable tape 110T and/or electronics housing 160 comprising over the encapsulated PCB. In many embodiments, adhesive 116B attaches cover 162 to adherent patch 110. In many embodiments, cover 162 attaches to adherent patch 110 with adhesive 116B, and cover 162 is adhered to the PCB module with an adhesive 161 on the upper surface of the electronics housing. Thus, the PCB module can be suspended above the adherent patch via connection to cover 162, for example with a gap 169 between the PCB module and adherent patch. In many embodiments, gap 169 permits air and/or water vapor to flow between the adherent patch and cover, for example through adherent patch 110 and cover 162, so as to provide patient comfort.

In many embodiments, adhesive 116B is configured such that adherent patch 110 and cover 162 can be breathable from the skin to above cover 162 and so as to allow moisture vapor and air to travel from the skin to outside cover 162. In many embodiments, adhesive 116B is applied in a pattern on adherent patch 110 such that the patch and cover can be flexible so as to avoid detachment with body movement. Adhesive 116B can be applied to upper side 110B of patch 110 and comprise many shapes, for example a continuous ring, dots, dashes around the perimeter of adherent patch 110 and cover 162. Adhesive 116B may comprise at least one of acrylate, silicone, synthetic rubber, synthetic resin, pressure sensitive adhesive (PSA), or acrylate pressure sensitive adhesive. Adhesive 16B may comprise a thickness within a range from about 0.0005″ to about 0.005″, for example within a range from about 0.001-0.005″. In many embodiments, adhesive 116B comprises a width near the edge of patch 110 and/or cover 162 within a range from about 2 to about 15 mm, for example from about 3 to about 7 near the periphery. In many embodiments with such widths and/or thickness near the edge of the patch and/or cover, the tissue adhesion may be at least about 30 oz/in, for example at least about 40 oz/in, such that the cover remains attached to the adhesive patch when the patient moves.

In many embodiments, the cover is adhered to adherent patch 110 comprising breathable tape 110T at least about 1 mm away from an outer edge of adherent patch 110. This positioning protects the adherent patch comprising breathable tape 110T from peeling away from the skin and minimizes edge peeling, for example because the edge of the patch can be thinner. In some embodiments, the edge of the cover may be adhered at the edge of the adherent patch, such that the cover can be slightly thicker at the edge of the patch which may, in some instances, facilitate peeling of the breathable tape from the skin of the patient.

Gap 169 extend from adherent patch 110 to the electronics module and/or PCB a distance within a range from about 0.25 mm to about 4 mm, for example within a range from about 0.5 mm to about 2 mm.

In many embodiments, the adherent device comprises a patch component and at least one electronics module. The patch component may comprise adherent patch 110 comprising the breathable tape with adhesive coating 116A, at least one electrode, for example electrode 114A and gel 114. The at least one electronics module can be separable from the patch component. In many embodiments, the at least one electronics module comprises the flex printed circuit board 120, electronic components 130, electronics housing 160 and cover 162, such that the flex printed circuit board, electronic components, electronics housing and cover are reusable and/or removable for recharging and data transfer, for example as described above. In many embodiments, adhesive 116B is coated on upper side 110A of adherent patch 110B, such that the electronics module can be adhered to and/or separated from the adhesive component. In specific embodiments, the electronic module can be adhered to the patch component with a releasable connection, for example with Velcro™, a known hook and loop connection, and/or snap directly to the electrodes. Two electronics modules can be provided, such that one electronics module can be worn by the patient while the other is charged, as described above. Monitoring with multiple adherent patches for an extended period is described in U.S. Pat. App. No. 60/972,537, the full disclosure of which has been previously incorporated herein by reference. Many patch components can be provided for monitoring over the extended period. For example, about 12 patches can be used to monitor the patient for at least 90 days with at least one electronics module, for example with two reusable electronics modules.

At least one electrode 112A can extend through at least one aperture 180A in the breathable tape 110.

In some embodiments, the adhesive patch may comprise a medicated patch that releases a medicament, such as antibiotic, beta-blocker, ACE inhibitor, diuretic, or steroid to reduce skin irritation. The adhesive patch may comprise a thin, flexible, breathable patch with a polymer grid for stiffening. This grid may be anisotropic, may use electronic components to act as a stiffener, may use electronics-enhanced adhesive elution, and may use an alternating elution of adhesive and steroid.

FIG. 1K shows at least one electrode 190 configured to electrically couple to a skin of the patient through a breathable tape 192. In many embodiments, at least one electrode 190 and breathable tape 192 comprise electrodes and materials similar to those described above. Electrode 190 and breathable tape 192 can be incorporated into adherent devices as described above, so as to provide electrical coupling between the skin and an electrode through the breathable tape, for example with the gel.

FIGS. 2A and 2B show components of an adherent device 200 comprising an adhesive patch 210 and connection structures to provide strain relief so as to decouple the patch from an electronics module 220. Adherent device 200 comprises many structures similar to those shown above. Adherent device 200 comprises electrodes 212A, 212B, 212C and 212D affixed to adherent patch 210. Adherent device 200 may comprise a gel, for example gel 214A over the electrodes, for example over electrode 212A. Electrodes 212A, 212B, 212C and 212D are connected to electronics module 220 with structures 223A, 223B, 223C and 223D. Electronics module 220 may comprise PCB with components mounted thereon, as described above. In many embodiments, structures 223A, 223B, 223C and 223D connect adhesive patch 210 to electronics module 220 with a flexible connection. In many embodiments, structures 223A, 223B, 223C and 223D comprise curved flexible wires, for example spirals and/or loops of wire that connect electrodes 212A, 212B, 212C and 212D to an electronics module 220. Structures 223A, 223B, 223C and 223D may comprise polyester film with silver traces coupled to silver/silver chloride electrodes to provide strain relief. Adhesive patch 210 comprises a lower side 210A toward the skin of the patient and an upper side 210B away from the skin of the patient. Adhesive 216B is disposed on upper side 210B of patch 210 to connect the adhesive patch to a cover, as described above. Electronics module 220 can be connected to the cover, as described above, such that module 220 is suspended above adhesive patch 210 with a gap 269. Gap 269 can decouple movement between patch 210 and electronic module 220. In many embodiments, gap 260 allows adhesive patch 210 and/or device 200 to breath, for example from the skin through the patch and cover to the outside of the cover, as described above.

In many embodiments, gap 269 can extend from adherent patch 210 to the electronics module 220 and/or PCB a distance within a range from about 0.25 mm to about 4 mm, for example within a range from about 0.5 mm to about 2 mm.

While the exemplary embodiments have been described in some detail, by way of example and for clarity of understanding, those of skill in the art will recognize that a variety of modifications, adaptations, and changes may be employed. Hence, the scope of the present invention should be limited solely by the appended claims.

Claims

1. An adherent device to monitor a patient for an extended period, the device comprising: a breathable tape comprising a porous material with an adhesive coating to adhere the breathable tape to a skin of the patient;at least one electrode affixed to the breathable tape and capable of electrically coupling to a skin of the patient;a printed circuit board connected to the breathable tape to support the printed circuit board with the breathable tape when the tape is adhered to the patient;electronic components electrically connected to the printed circuit board and coupled to the at least one electrode to measure physiologic signals of the patient;an electronics housing adhered to at least one of the electronics components or the printed circuit board; anda breathable cover disposed over the circuit board and electronic components such that the electronics housing is disposed between the cover and electronics components, wherein the breathable cover is connected to at least one of the electronics components, the printed circuit board or the breathable tape.
2. The adherent device of claim 1 wherein the printed circuit board is connected to the breathable tape with an intermediate connector.
3. The adherent device of claim 1 further comprising a gap extending between the breathable tape and the printed circuit board.
4. The adherent device of claim 3 wherein the gap extends between the breathable tape and printed circuit board for a distance from about 0.25 mm to about 4 mm to allow the tape to breathe under the printed circuit board when the tape is adhered to the patient.
5. The adherent device of claim 1 wherein the breathable cover comprises a stretchable material.
6. The adherent device of claim 5 wherein the stretchable material comprises at least one of polyester fabric, nylon or polyamide fabric.
7. The adherent device of claim 5 wherein the stretchable material comprises from about 5% to about 25% elastane fabric.
8. The adherent device of claim 5 wherein the stretchable material comprises at least about 100% elongation.
9. The adherent device of claim 5 wherein the stretchable material comprises an elastomeric material comprising at least about 400% elongation.
10. The adherent device of claim 1 wherein the breathable cover comprises at least one of a water repellant outside coating to repel water or hydrophilic inside coating to wick moisture away from the skin of the patient.
11. The adherent device of claim 10 wherein the breathable cover comprises the water repellant outside coating and the hydrophilic inside coating.
12. The adherent device of claim 1 wherein the breathable cover comprises fabric weight from about 100 to 200 grams per square meter.
13. The adherent device of claim 1 further comprising a flexible connection structure to couple the electrodes to the printed circuit board so as to relieve strain between the electrodes and the printed circuit board.
14. The adherent device of claim 13 wherein the printed circuit board is adhered to the breathable tape at a central location and wherein the breathable tape is configured to stretch with the skin of the patient away from the central location.
15. The adherent device of claim 13 wherein the flexible connection structure supports the printed circuit board with a gap between the printed circuit board and the breathable tape.
16. The adherent device of claim 13 wherein the flexible connection structure comprises at least one of shielded wires, non-shielded wires, a flexible printed circuit board or polyester film with silver printing.
17. The adherent device of claim 1 wherein the breathable tape comprises a flexible material and a thickness from about 0.005″ to about 0.010″.
18. The adherent device of claim 1 wherein the breathable tape comprises a backing, and the backing comprises a polyester knit fabric and a thickness from about 0.005″ to about 0.010″.
19. The adherent device of claim 1 wherein the breathable tape comprises an acrylate pressure sensitive adhesive on an underside of the tape, the adhesive having a thickness less than about 0.004″ to allow the tape to breath when the adhesive is applied to the patient.
20. The adherent device of claim 1 wherein the electronics housing comprises a waterproof encapsulant to protect the printed circuit board and the electronic components from moisture and/or mechanical forces.
21. The adherent device of claim 1 further comprising a gel cover positioned over the breathable tape to inhibit a flow of a gel through the breathable tape and wherein the printed circuit board is located over the gel cover such that the gel cover is disposed between the breathable tape and the printed circuit board.
22. The adherent device of claim 21 wherein the gel cover comprises at least one of a polyurethane film or polyurethane non-woven backing and an acrylate pressure sensitive adhesive.
23. The adherent device of claim 21 wherein the gel cover comprises a porosity of at least about 200 sec./100 cc/in^2 to protect the gel from external moisture.
24. The adherent device of claim 21 wherein an edge of the gel cover extends from about 5 to about 15 mm beyond an edge of a gel over the at least one electrode.
25. The adherent device of claim 21 wherein the breathable tape comprises a knit polyester fabric backing and the gel cover comprises a polyurethane, film backing.
26. The adherent device of claim 21 wherein the breathable tape comprises a first porosity and wherein the gel cover comprises a breathable tape with a second porosity, the second porosity less than the first porosity to inhibit flow of the gel through the breathable tape having the first porosity.
27. The adherent device of claim 21 wherein breathable tape, the at least one electrode, the gel cover, and the gel are separable from the printed circuit board, the electronic components, the breathable cover, and the electronics housing, such that the printed circuit board, the electronic components, the breathable cover, and electronics housing are reusable.
28. The adherent device of claim 1 wherein the at least one electrode extends through at least one aperture in the breathable tape.
29. The adherent device of claim 1 further comprising at least one gel disposed over a contact surface of the at least one electrode to electrically connect the electrode to the skin.
30. The adherent device of claim 1 wherein the at least one electrode is configured to electrically couple to the printed circuit board through the breathable tape.
31. The adherent device of claim 1 further comprising an adhesive disposed around the breathable tape to connect the cover to the breathable tape.
32. The adherent device of claim 1 wherein the breathable tape comprises an MVTR of at least about 400 g/m2/24 hrs.
33. The adherent device of claim 32 further comprising a gel cover positioned over the breathable tape and wherein an MVTR through the breathable tape and the gel cover comprises at least about 400 g/m2/24 hrs.
34. The adherent device of claim 33 wherein an MVTR through the breathable tape, the gel cover and the breathable cover comprises at least about 400 g/m2/24 hrs.
35. The adherent device of claim 1, wherein the breathable cover fits loosely over the electronics housing, such that a portion of the breathable cover can move with respect to the electronics housing.
36. The adherent device of claim 35, wherein the electronics housing is smooth, such that the breathable cover is slidably coupled with the electronics housing.
37. The adherent device of claim 1, wherein the electronic components include wireless communications circuitry that transmits at least one physiologic signal to a remote server.
38. The adherent device of claim 37, wherein the electronic components comprise impedance circuitry, and wherein the wireless communications circuitry is coupled to the impedance circuitry to transmit to the remote server a hydration signal derived from an output of the impedance circuitry.
39. The adherent device of claim 37, wherein the electronic components comprise electrocardiogram circuitry, and wherein the wireless communications circuitry is coupled to the electrocardiogram circuitry to transmit to the remote server an electrocardiogram signal derived from an output of the electrocardiogram circuitry.
40. The adherent device of claim 37, wherein the electronic components comprise an accelerometer, and wherein the wireless communications circuitry is coupled to the accelerometer to transmit to the remote server an inclination signal derived from an output of the accelerometer.

CROSS-REFERENCES TO RELATED APPLICATIONS

The present application claims the benefit under 35 USC 119(e) of U.S. Provisional Application Nos. 60/972,629 and 60/972,537 both filed Sep. 14, 2007, and 61/055,645 and 61/055,666 both filed May 23, 2008; the full disclosures of which are incorporated herein by reference in their entirety. The subject matter of the present application is related to the following applications: 60/972,512; 60/972,329; 60/972,354; 60/972,616; 60/972,363; 60/972,343; 60/972,581; 60/972,316; 60/972,333; 60/972,359; 60/972,336; 60/972,340 all of which were filed on Sep. 14, 2007; 61/046,196 filed Apr. 18, 2008; 61/047,875 filed Apr. 25, 2008; 61/055,656 and 61/055,662 both filed May 23, 2008; and 61/079,746 filed Jul. 10, 2008. The following applications are being filed concurrently with the present application, on Sep. 12, 2008: Ser. No. 12/209,279 entitled “Multi-Sensor Patient Monitor to Detect Impending Cardiac Decompensation Prediction”; Ser. No. 12/209,288 entitled “Adherent Device with Multiple Physiological Sensors”; Ser. No. 12/209,430 entitled “Injectable Device for Physiological Monitoring”; Ser. No. 12/209,479 entitled “Delivery System for Injectable Physiological Monitoring System”; Ser. No. 12/209,262 entitled “Adherent Device for Cardiac Rhythm Management”; Ser. No. 12/209,268 entitled “Adherent Device for Respiratory Monitoring”; Ser. No. 12/209,269 entitled “Adherent Athletic Monitor”; Ser. No. 12/209,259 entitled “Adherent Emergency Monitor”; Ser. No. 12/209,276 entitled “Medical Device Automatic Start-up upon Contact to Patient Tissue”; Ser. No. 12/210,078 entitled “System and Methods for Wireless Body Fluid Monitoring”; Ser. No. 12/209,265 entitled “Adherent Cardiac Monitor with Advanced Sensing Capabilities”; Ser. No. 12/209,292 entitled “Adherent Device for Sleep Disordered Breathing”; Ser. No. 12/209,278 entitled “Dynamic Pairing of Patients to Data Collection Gateways”; Ser. No. 12/209,508 entitled “Adherent Multi-Sensor Device with Implantable Device Communications Capabilities”; Ser. No. 12/209,528 entitled “Data Collection in a Multi-Sensor Patient Monitor”; Ser. No. 12/209,271 entitled “Adherent Multi-Sensor Device with Empathic Monitoring”; Ser. No. 12/209,274 entitled “Energy Management for Adherent Patient Monitor”; and Ser. No. 12/209,294 entitled “Tracking and Security for Adherent Patient Monitor.”

US Referenced Citations (695)

Number	Name	Date	Kind
834261	Chambers	Oct 1906	A
2087124	Smith et al.	Jul 1937	A
2184511	Bagno et al.	Dec 1939	A
3170459	Phipps et al.	Feb 1965	A
3232291	Parker	Feb 1966	A
3370459	Cescati	Feb 1968	A
3517999	Weaver	Jun 1970	A
3620216	Szymanski	Nov 1971	A
3677260	Funfstuck et al.	Jul 1972	A
3805769	Sessions	Apr 1974	A
3845757	Weyer	Nov 1974	A
3874368	Asrican	Apr 1975	A
3882853	Gofman et al.	May 1975	A
3942517	Bowles et al.	Mar 1976	A
3972329	Kaufman	Aug 1976	A
4008712	Nyboer	Feb 1977	A
4024312	Korpman	May 1977	A
4077406	Sandhage et al.	Mar 1978	A
4121573	Crovella et al.	Oct 1978	A
4141366	Cross, Jr. et al.	Feb 1979	A
RE30101	Kubicek et al.	Sep 1979	E
4185621	Morrow	Jan 1980	A
4216462	McGrath et al.	Aug 1980	A
4300575	Wilson	Nov 1981	A
4308872	Watson et al.	Jan 1982	A
4358678	Lawrence	Nov 1982	A
4409983	Albert	Oct 1983	A
4450527	Sramek	May 1984	A
4451254	Dinius et al.	May 1984	A
4478223	Allor	Oct 1984	A
4498479	Martio et al.	Feb 1985	A
4522211	Bare et al.	Jun 1985	A
4661103	Harman	Apr 1987	A
4664129	Helzel et al.	May 1987	A
4669480	Hoffman	Jun 1987	A
4673387	Phillips et al.	Jun 1987	A
4681118	Asai et al.	Jul 1987	A
4692685	Blaze	Sep 1987	A
4699146	Sieverding	Oct 1987	A
4721110	Lampadius	Jan 1988	A
4730611	Lamb	Mar 1988	A
4781200	Baker	Nov 1988	A
4793362	Tedner	Dec 1988	A
4838273	Cartmell	Jun 1989	A
4838279	Fore	Jun 1989	A
4850370	Dower	Jul 1989	A
4880004	Baker, Jr. et al.	Nov 1989	A
4895163	Libke et al.	Jan 1990	A
4911175	Shizgal	Mar 1990	A
4945916	Kretschmer et al.	Aug 1990	A
4955381	Way et al.	Sep 1990	A
4966158	Honma et al.	Oct 1990	A
4981139	Pfohl	Jan 1991	A
4988335	Prindle et al.	Jan 1991	A
4989612	Fore	Feb 1991	A
5001632	Hall-Tipping	Mar 1991	A
5012810	Strand et al.	May 1991	A
5025791	Niwa	Jun 1991	A
5027824	Dougherty et al.	Jul 1991	A
5050612	Matsumura	Sep 1991	A
5063937	Ezenwa et al.	Nov 1991	A
5080099	Way et al.	Jan 1992	A
5083563	Collins	Jan 1992	A
5086781	Bookspan	Feb 1992	A
5113869	Nappholz et al.	May 1992	A
5125412	Thornton	Jun 1992	A
5133355	Strand et al.	Jul 1992	A
5140985	Schroeder et al.	Aug 1992	A
5150708	Brooks	Sep 1992	A
5168874	Segalowitz	Dec 1992	A
5226417	Swedlow et al.	Jul 1993	A
5241300	Buschmann	Aug 1993	A
5257627	Rapoport	Nov 1993	A
5271411	Ripley et al.	Dec 1993	A
5273532	Niezink et al.	Dec 1993	A
5282840	Hudrlik	Feb 1994	A
5291013	Nafarrate et al.	Mar 1994	A
5297556	Shankar	Mar 1994	A
5301677	Hsung	Apr 1994	A
5319363	Welch et al.	Jun 1994	A
5331966	Bennett et al.	Jul 1994	A
5335664	Nagashima	Aug 1994	A
5343869	Pross et al.	Sep 1994	A
5353793	Bornn	Oct 1994	A
5362069	Hall-Tipping	Nov 1994	A
5375604	Kelly et al.	Dec 1994	A
5411530	Akhtar	May 1995	A
5437285	Verrier et al.	Aug 1995	A
5443073	Wang et al.	Aug 1995	A
5449000	Libke et al.	Sep 1995	A
5450845	Axelgaard	Sep 1995	A
5454377	Dzwonczyk et al.	Oct 1995	A
5464012	Falcone	Nov 1995	A
5469859	Tsoglin et al.	Nov 1995	A
5482036	Diab et al.	Jan 1996	A
5503157	Sramek	Apr 1996	A
5511548	Riazzi et al.	Apr 1996	A
5511553	Segalowitz	Apr 1996	A
5518001	Snell	May 1996	A
5523742	Simkins et al.	Jun 1996	A
5529072	Sramek	Jun 1996	A
5544661	Davis et al.	Aug 1996	A
5558638	Evers et al.	Sep 1996	A
5560368	Berger	Oct 1996	A
5564429	Bornn et al.	Oct 1996	A
5564434	Halperin et al.	Oct 1996	A
5566671	Lyons	Oct 1996	A
5575284	Athan et al.	Nov 1996	A
5607454	Cameron et al.	Mar 1997	A
5632272	Diab et al.	May 1997	A
5634468	Platt et al.	Jun 1997	A
5642734	Ruben et al.	Jul 1997	A
5673704	Marchlinski et al.	Oct 1997	A
5678562	Sellers	Oct 1997	A
5687717	Halpern et al.	Nov 1997	A
5718234	Warden et al.	Feb 1998	A
5724025	Tavori	Mar 1998	A
5738107	Martinsen et al.	Apr 1998	A
5748103	Flach et al.	May 1998	A
5767791	Stoop et al.	Jun 1998	A
5769793	Pincus et al.	Jun 1998	A
5772508	Sugita et al.	Jun 1998	A
5772586	Heinonen et al.	Jun 1998	A
5778882	Raymond et al.	Jul 1998	A
5788643	Feldman	Aug 1998	A
5803915	Kremenchugsky et al.	Sep 1998	A
5807272	Kun	Sep 1998	A
5814079	Kieval	Sep 1998	A
5817035	Sullivan	Oct 1998	A
5833603	Kovacs et al.	Nov 1998	A
5836990	Li	Nov 1998	A
5855614	Stevens et al.	Jan 1999	A
5860860	Clayman	Jan 1999	A
5862802	Bird	Jan 1999	A
5862803	Besson et al.	Jan 1999	A
5865733	Malinouskas et al.	Feb 1999	A
5876353	Riff	Mar 1999	A
5904708	Goedeke	May 1999	A
5935079	Swanson et al.	Aug 1999	A
5941831	Turcott	Aug 1999	A
5944659	Flach et al.	Aug 1999	A
5949636	Johnson et al.	Sep 1999	A
5957854	Besson et al.	Sep 1999	A
5957861	Combs et al.	Sep 1999	A
5964703	Goodman et al.	Oct 1999	A
5970986	Bolz et al.	Oct 1999	A
5984102	Tay	Nov 1999	A
5987352	Klein et al.	Nov 1999	A
6007532	Netherly	Dec 1999	A
6027523	Schmieding	Feb 2000	A
6045513	Stone et al.	Apr 2000	A
6047203	Sackner et al.	Apr 2000	A
6047259	Campbell et al.	Apr 2000	A
6049730	Kristbjarnarson	Apr 2000	A
6050267	Nardella et al.	Apr 2000	A
6050951	Friedman et al.	Apr 2000	A
6052615	Feild et al.	Apr 2000	A
6067467	John	May 2000	A
6080106	Lloyd et al.	Jun 2000	A
6081735	Diab et al.	Jun 2000	A
6095991	Krausman et al.	Aug 2000	A
6102856	Groff et al.	Aug 2000	A
6104949	Pitts Crick et al.	Aug 2000	A
6112224	Peifer et al.	Aug 2000	A
6117077	Del Mar et al.	Sep 2000	A
6125297	Siconolfi	Sep 2000	A
6129744	Boute	Oct 2000	A
6141575	Price	Oct 2000	A
6144878	Schroeppel et al.	Nov 2000	A
6164284	Schulman et al.	Dec 2000	A
6181963	Chin et al.	Jan 2001	B1
6185452	Schulman et al.	Feb 2001	B1
6190313	Hinkle	Feb 2001	B1
6190324	Kieval et al.	Feb 2001	B1
6198394	Jacobsen et al.	Mar 2001	B1
6198955	Axelgaard et al.	Mar 2001	B1
6208894	Schulman et al.	Mar 2001	B1
6212427	Hoover	Apr 2001	B1
6213942	Flach et al.	Apr 2001	B1
6225901	Kail, IV	May 2001	B1
6245021	Stampfer	Jun 2001	B1
6259939	Rogel	Jul 2001	B1
6272377	Sweeney et al.	Aug 2001	B1
6277078	Porat et al.	Aug 2001	B1
6287252	Lugo	Sep 2001	B1
6289238	Besson et al.	Sep 2001	B1
6290646	Cosentino et al.	Sep 2001	B1
6295466	Ishikawa et al.	Sep 2001	B1
6305943	Pougatchev et al.	Oct 2001	B1
6306088	Krausman et al.	Oct 2001	B1
6308094	Shusterman et al.	Oct 2001	B1
6312378	Bardy	Nov 2001	B1
6315721	Schulman et al.	Nov 2001	B2
6327487	Stratbucker	Dec 2001	B1
6336903	Bardy	Jan 2002	B1
6339722	Heethaar et al.	Jan 2002	B1
6343140	Brooks	Jan 2002	B1
6347245	Lee et al.	Feb 2002	B1
6358208	Lang et al.	Mar 2002	B1
6385473	Haines et al.	May 2002	B1
6398727	Bui et al.	Jun 2002	B1
6400982	Sweeney et al.	Jun 2002	B2
6411853	Millot et al.	Jun 2002	B1
6416471	Kumar et al.	Jul 2002	B1
6442422	Duckert	Aug 2002	B1
6450820	Palsson et al.	Sep 2002	B1
6450953	Place et al.	Sep 2002	B1
6454707	Casscells, III et al.	Sep 2002	B1
6454708	Ferguson et al.	Sep 2002	B1
6459930	Takehara et al.	Oct 2002	B1
6463328	John	Oct 2002	B1
6473640	Erlebacher	Oct 2002	B1
6480733	Turcott	Nov 2002	B1
6480734	Zhang et al.	Nov 2002	B1
6490478	Zhang et al.	Dec 2002	B1
6491647	Bridger et al.	Dec 2002	B1
6494829	New, Jr. et al.	Dec 2002	B1
6496715	Lee et al.	Dec 2002	B1
6512949	Combs et al.	Jan 2003	B1
6520967	Cauthen	Feb 2003	B1
6527711	Stivoric et al.	Mar 2003	B1
6527729	Turcott	Mar 2003	B1
6544173	West et al.	Apr 2003	B2
6544174	West et al.	Apr 2003	B2
6551251	Zuckerwar et al.	Apr 2003	B2
6551252	Sackner et al.	Apr 2003	B2
6569160	Goldin et al.	May 2003	B1
6572557	Tchou et al.	Jun 2003	B2
6572636	Hagen et al.	Jun 2003	B1
6577139	Cooper	Jun 2003	B2
6577893	Besson et al.	Jun 2003	B1
6579231	Phipps	Jun 2003	B1
6580942	Willshire	Jun 2003	B1
6584343	Ransbury et al.	Jun 2003	B1
6587715	Singer	Jul 2003	B2
6589170	Flach et al.	Jul 2003	B1
6595927	Pitts-Crick et al.	Jul 2003	B2
6595929	Stivoric et al.	Jul 2003	B2
6600949	Turcott	Jul 2003	B1
6602201	Hepp et al.	Aug 2003	B1
6605038	Teller et al.	Aug 2003	B1
6611705	Hopman et al.	Aug 2003	B2
6616606	Petersen et al.	Sep 2003	B1
6622042	Thacker	Sep 2003	B1
6636754	Baura et al.	Oct 2003	B1
6641542	Cho et al.	Nov 2003	B2
6645153	Kroll et al.	Nov 2003	B2
6649829	Garber et al.	Nov 2003	B2
6650917	Diab et al.	Nov 2003	B2
6658300	Govari et al.	Dec 2003	B2
6659947	Carter et al.	Dec 2003	B1
6659949	Lang et al.	Dec 2003	B1
6687540	Marcovecchio	Feb 2004	B2
6697658	Al-Ali	Feb 2004	B2
RE38476	Diab et al.	Mar 2004	E
6699200	Cao et al.	Mar 2004	B2
6701271	Willner et al.	Mar 2004	B2
6714813	Ishigooka et al.	Mar 2004	B2
RE38492	Diab et al.	Apr 2004	E
6721594	Conley et al.	Apr 2004	B2
6728572	Hsu et al.	Apr 2004	B2
6748269	Thompson et al.	Jun 2004	B2
6749566	Russ	Jun 2004	B2
6751498	Greenberg et al.	Jun 2004	B1
6760617	Ward et al.	Jul 2004	B2
6773396	Flach et al.	Aug 2004	B2
6775566	Nissila	Aug 2004	B2
6790178	Mault et al.	Sep 2004	B1
6795722	Sheraton et al.	Sep 2004	B2
6814706	Barton et al.	Nov 2004	B2
6816744	Garfield et al.	Nov 2004	B2
6821249	Casscells, III et al.	Nov 2004	B2
6824515	Suorsa et al.	Nov 2004	B2
6827690	Bardy	Dec 2004	B2
6829503	Alt	Dec 2004	B2
6858006	MacCarter et al.	Feb 2005	B2
6871211	Labounty et al.	Mar 2005	B2
6878121	Krausman et al.	Apr 2005	B2
6879850	Kimball	Apr 2005	B2
6881191	Oakley et al.	Apr 2005	B2
6887201	Bardy	May 2005	B2
6890096	Tokita et al.	May 2005	B2
6893396	Schulze et al.	May 2005	B2
6894204	Dunshee	May 2005	B2
6906530	Geisel	Jun 2005	B2
6912414	Tong	Jun 2005	B2
6936006	Sabra	Aug 2005	B2
6940403	Kail, IV	Sep 2005	B2
6942622	Turcott	Sep 2005	B1
6952695	Trinks et al.	Oct 2005	B1
6970742	Mann et al.	Nov 2005	B2
6972683	Lestienne et al.	Dec 2005	B2
6978177	Chen et al.	Dec 2005	B1
6980851	Zhu et al.	Dec 2005	B2
6980852	Jersey-Willuhn et al.	Dec 2005	B2
6985078	Suzuki et al.	Jan 2006	B2
6987965	Ng et al.	Jan 2006	B2
6988989	Weiner et al.	Jan 2006	B2
6993378	Wiederhold et al.	Jan 2006	B2
6997879	Turcott	Feb 2006	B1
7003346	Singer	Feb 2006	B2
7018338	Vetter et al.	Mar 2006	B2
7020508	Stivoric et al.	Mar 2006	B2
7027862	Dahl et al.	Apr 2006	B2
7041062	Friedrichs et al.	May 2006	B2
7044911	Drinan et al.	May 2006	B2
7047067	Gray et al.	May 2006	B2
7050846	Sweeney et al.	May 2006	B2
7054679	Hirsh	May 2006	B2
7059767	Tokita et al.	Jun 2006	B2
7088242	Aupperle et al.	Aug 2006	B2
7113826	Henry et al.	Sep 2006	B2
7118531	Krill	Oct 2006	B2
7127370	Kelly, Jr. et al.	Oct 2006	B2
7129836	Lawson et al.	Oct 2006	B2
7130396	Rogers et al.	Oct 2006	B2
7130679	Parsonnet et al.	Oct 2006	B2
7133716	Kraemer et al.	Nov 2006	B2
7136697	Singer	Nov 2006	B2
7136703	Cappa et al.	Nov 2006	B1
7142907	Xue et al.	Nov 2006	B2
7149574	Yun et al.	Dec 2006	B2
7149773	Haller et al.	Dec 2006	B2
7153262	Stivoric et al.	Dec 2006	B2
7156807	Carter et al.	Jan 2007	B2
7156808	Quy	Jan 2007	B2
7160252	Cho et al.	Jan 2007	B2
7160253	Nissila	Jan 2007	B2
7166063	Rahman et al.	Jan 2007	B2
7167743	Heruth et al.	Jan 2007	B2
7184821	Belalcazar et al.	Feb 2007	B2
7191000	Zhu et al.	Mar 2007	B2
7194306	Turcott	Mar 2007	B1
7206630	Tarler	Apr 2007	B1
7212849	Zhang et al.	May 2007	B2
7215984	Diab et al.	May 2007	B2
7215991	Besson et al.	May 2007	B2
7238159	Banet et al.	Jul 2007	B2
7248916	Bardy	Jul 2007	B2
7251524	Hepp et al.	Jul 2007	B1
7257438	Kinast	Aug 2007	B2
7261690	Teller et al.	Aug 2007	B2
7277741	Debreczeny et al.	Oct 2007	B2
7284904	Tokita et al.	Oct 2007	B2
7285090	Stivoric et al.	Oct 2007	B2
7294105	Islam	Nov 2007	B1
7295879	Denker et al.	Nov 2007	B2
7297119	Westbrook et al.	Nov 2007	B2
7318808	Tarassenko et al.	Jan 2008	B2
7319386	Collins, Jr. et al.	Jan 2008	B2
7336187	Hubbard, Jr. et al.	Feb 2008	B2
7346380	Axelgaard et al.	Mar 2008	B2
7382247	Welch et al.	Jun 2008	B2
7384398	Gagnadre et al.	Jun 2008	B2
7390299	Weiner et al.	Jun 2008	B2
7395106	Ryu et al.	Jul 2008	B2
7423526	Despotis	Sep 2008	B2
7423537	Bonnet et al.	Sep 2008	B2
7443302	Reeder et al.	Oct 2008	B2
7450024	Wildman et al.	Nov 2008	B2
7468032	Stahmann et al.	Dec 2008	B2
7701227	Saulnier et al.	Apr 2010	B2
20010047127	New, Jr. et al.	Nov 2001	A1
20020019588	Marro et al.	Feb 2002	A1
20020028989	Pelletier et al.	Mar 2002	A1
20020032581	Reitberg	Mar 2002	A1
20020045836	Alkawwas	Apr 2002	A1
20020088465	Hill	Jul 2002	A1
20020099277	Harry et al.	Jul 2002	A1
20020116009	Fraser et al.	Aug 2002	A1
20020123672	Christophersom et al.	Sep 2002	A1
20020123674	Plicchi et al.	Sep 2002	A1
20020138017	Bui et al.	Sep 2002	A1
20020167389	Uchikoba et al.	Nov 2002	A1
20030009092	Parker	Jan 2003	A1
20030023184	Pitts-Crick et al.	Jan 2003	A1
20030028221	Zhu et al.	Feb 2003	A1
20030028327	Brunner et al.	Feb 2003	A1
20030051144	Williams	Mar 2003	A1
20030055460	Owens et al.	Mar 2003	A1
20030083581	Taha et al.	May 2003	A1
20030085717	Cooper	May 2003	A1
20030087244	McCarthy	May 2003	A1
20030092975	Casscells, III et al.	May 2003	A1
20030093125	Zhu et al.	May 2003	A1
20030093298	Hernandez et al.	May 2003	A1
20030100367	Cooke	May 2003	A1
20030105411	Smallwood et al.	Jun 2003	A1
20030135127	Sackner et al.	Jul 2003	A1
20030143544	McCarthy	Jul 2003	A1
20030149349	Jensen	Aug 2003	A1
20030187370	Kodama	Oct 2003	A1
20030191503	Zhu et al.	Oct 2003	A1
20030212319	Magill	Nov 2003	A1
20030221687	Kaigler	Dec 2003	A1
20030233129	Matos	Dec 2003	A1
20040006279	Arad (Abboud)	Jan 2004	A1
20040010303	Bolea et al.	Jan 2004	A1
20040015058	Besson et al.	Jan 2004	A1
20040019292	Drinan et al.	Jan 2004	A1
20040044293	Burton	Mar 2004	A1
20040049132	Barron et al.	Mar 2004	A1
20040073094	Baker	Apr 2004	A1
20040073126	Rowlandson	Apr 2004	A1
20040077954	Oakley et al.	Apr 2004	A1
20040100376	Lye et al.	May 2004	A1
20040102683	Khanuja et al.	May 2004	A1
20040106951	Edman et al.	Jun 2004	A1
20040127790	Lang et al.	Jul 2004	A1
20040133079	Mazar et al.	Jul 2004	A1
20040133081	Teller et al.	Jul 2004	A1
20040134496	Cho et al.	Jul 2004	A1
20040143170	DuRousseau	Jul 2004	A1
20040147969	Mann et al.	Jul 2004	A1
20040152956	Korman	Aug 2004	A1
20040158132	Zaleski	Aug 2004	A1
20040167389	Brabrand	Aug 2004	A1
20040172080	Stadler et al.	Sep 2004	A1
20040199056	Husemann et al.	Oct 2004	A1
20040215240	Lovett et al.	Oct 2004	A1
20040215247	Bolz	Oct 2004	A1
20040220639	Mulligan et al.	Nov 2004	A1
20040225199	Evanyk et al.	Nov 2004	A1
20040225203	Jemison et al.	Nov 2004	A1
20040243018	Organ et al.	Dec 2004	A1
20040267142	Paul	Dec 2004	A1
20050015094	Keller	Jan 2005	A1
20050015095	Keller	Jan 2005	A1
20050020935	Helzel et al.	Jan 2005	A1
20050027175	Yang	Feb 2005	A1
20050027204	Kligfield et al.	Feb 2005	A1
20050027207	Westbrook et al.	Feb 2005	A1
20050027918	Govindarajulu et al.	Feb 2005	A1
20050043675	Pastore et al.	Feb 2005	A1
20050054944	Nakada et al.	Mar 2005	A1
20050059867	Chung	Mar 2005	A1
20050065445	Arzbaecher et al.	Mar 2005	A1
20050065571	Imran	Mar 2005	A1
20050070768	Zhu et al.	Mar 2005	A1
20050070778	Lackey et al.	Mar 2005	A1
20050080346	Gianchandani et al.	Apr 2005	A1
20050080460	Wang et al.	Apr 2005	A1
20050080463	Stahmann et al.	Apr 2005	A1
20050085734	Tehrani	Apr 2005	A1
20050091338	de la Huerga	Apr 2005	A1
20050096513	Ozguz et al.	May 2005	A1
20050113703	Farringdon et al.	May 2005	A1
20050124878	Sharony	Jun 2005	A1
20050124901	Misczynski et al.	Jun 2005	A1
20050124908	Belalcazar et al.	Jun 2005	A1
20050131288	Turner et al.	Jun 2005	A1
20050137464	Bomba	Jun 2005	A1
20050137626	Pastore et al.	Jun 2005	A1
20050148895	Misczynski et al.	Jul 2005	A1
20050158539	Murphy et al.	Jul 2005	A1
20050177038	Kolpin et al.	Aug 2005	A1
20050187482	O'Brien et al.	Aug 2005	A1
20050187796	Rosenfeld et al.	Aug 2005	A1
20050192488	Bryenton et al.	Sep 2005	A1
20050197654	Edman et al.	Sep 2005	A1
20050203433	Singer	Sep 2005	A1
20050203435	Nakada	Sep 2005	A1
20050203436	Davies	Sep 2005	A1
20050203637	Edman et al.	Sep 2005	A1
20050206518	Welch et al.	Sep 2005	A1
20050215914	Bornzin et al.	Sep 2005	A1
20050215918	Frantz et al.	Sep 2005	A1
20050228234	Yang	Oct 2005	A1
20050228238	Monitzer	Oct 2005	A1
20050228244	Banet	Oct 2005	A1
20050239493	Batkin et al.	Oct 2005	A1
20050240087	Keenan et al.	Oct 2005	A1
20050251044	Hoctor et al.	Nov 2005	A1
20050256418	Mietus et al.	Nov 2005	A1
20050261598	Banet et al.	Nov 2005	A1
20050261743	Kroll	Nov 2005	A1
20050267376	Marossero et al.	Dec 2005	A1
20050267377	Marossero et al.	Dec 2005	A1
20050267381	Benditt et al.	Dec 2005	A1
20050273023	Bystrom et al.	Dec 2005	A1
20050277841	Shennib	Dec 2005	A1
20050277842	Silva	Dec 2005	A1
20050277992	Koh et al.	Dec 2005	A1
20050280531	Fadem et al.	Dec 2005	A1
20050283197	Daum et al.	Dec 2005	A1
20050288601	Wood et al.	Dec 2005	A1
20060004300	Kennedy	Jan 2006	A1
20060004377	Keller	Jan 2006	A1
20060009697	Banet et al.	Jan 2006	A1
20060009701	Nissila et al.	Jan 2006	A1
20060010090	Brockway et al.	Jan 2006	A1
20060020218	Freeman et al.	Jan 2006	A1
20060025661	Sweeney et al.	Feb 2006	A1
20060030781	Shennib	Feb 2006	A1
20060030782	Shennib	Feb 2006	A1
20060031102	Teller et al.	Feb 2006	A1
20060041280	Stahmann et al.	Feb 2006	A1
20060047215	Newman et al.	Mar 2006	A1
20060052678	Drinan et al.	Mar 2006	A1
20060058543	Walter et al.	Mar 2006	A1
20060058593	Drinan et al.	Mar 2006	A1
20060064030	Cosentino et al.	Mar 2006	A1
20060064040	Berger et al.	Mar 2006	A1
20060064142	Chavan et al.	Mar 2006	A1
20060066449	Johnson	Mar 2006	A1
20060074283	Henderson et al.	Apr 2006	A1
20060074462	Verhoef	Apr 2006	A1
20060075257	Martis et al.	Apr 2006	A1
20060084881	Korzinov et al.	Apr 2006	A1
20060085049	Cory et al.	Apr 2006	A1
20060089679	Zhu et al.	Apr 2006	A1
20060094948	Gough et al.	May 2006	A1
20060102476	Niwa et al.	May 2006	A1
20060116592	Zhou et al.	Jun 2006	A1
20060122474	Teller et al.	Jun 2006	A1
20060135858	Nidd et al.	Jun 2006	A1
20060142654	Rytky	Jun 2006	A1
20060142820	Von Arx et al.	Jun 2006	A1
20060149168	Czarnek	Jul 2006	A1
20060155183	Kroecker et al.	Jul 2006	A1
20060155200	Ng	Jul 2006	A1
20060161073	Singer	Jul 2006	A1
20060161205	Mitrani et al.	Jul 2006	A1
20060161459	Rosenfeld et al.	Jul 2006	A9
20060173257	Nagai et al.	Aug 2006	A1
20060173269	Glossop	Aug 2006	A1
20060195020	Martin et al.	Aug 2006	A1
20060195039	Drew et al.	Aug 2006	A1
20060195097	Evans et al.	Aug 2006	A1
20060195144	Giftakis et al.	Aug 2006	A1
20060202816	Crump et al.	Sep 2006	A1
20060212097	Varadan et al.	Sep 2006	A1
20060224051	Teller et al.	Oct 2006	A1
20060224072	Shennib	Oct 2006	A1
20060224079	Washchuk	Oct 2006	A1
20060235281	Tuccillo	Oct 2006	A1
20060235316	Ungless et al.	Oct 2006	A1
20060235489	Drew et al.	Oct 2006	A1
20060241641	Albans et al.	Oct 2006	A1
20060241701	Markowitz et al.	Oct 2006	A1
20060241722	Thacker et al.	Oct 2006	A1
20060247545	St. Martin	Nov 2006	A1
20060252999	Devaul et al.	Nov 2006	A1
20060253005	Drinan et al.	Nov 2006	A1
20060253044	Zhang et al.	Nov 2006	A1
20060258952	Stahmann et al.	Nov 2006	A1
20060264730	Stivoric et al.	Nov 2006	A1
20060264767	Shennib	Nov 2006	A1
20060264776	Stahmann et al.	Nov 2006	A1
20060271116	Stahmann et al.	Nov 2006	A1
20060276714	Holt et al.	Dec 2006	A1
20060281981	Jang et al.	Dec 2006	A1
20060281996	Kuo et al.	Dec 2006	A1
20060293571	Bao et al.	Dec 2006	A1
20060293609	Stahmann et al.	Dec 2006	A1
20070010721	Chen et al.	Jan 2007	A1
20070010750	Ueno et al.	Jan 2007	A1
20070015973	Nanikashvili	Jan 2007	A1
20070015976	Miesel et al.	Jan 2007	A1
20070016089	Fischell et al.	Jan 2007	A1
20070021678	Beck et al.	Jan 2007	A1
20070021790	Kieval et al.	Jan 2007	A1
20070021792	Kieval et al.	Jan 2007	A1
20070021794	Kieval et al.	Jan 2007	A1
20070021796	Kieval et al.	Jan 2007	A1
20070021797	Kieval et al.	Jan 2007	A1
20070021798	Kieval et al.	Jan 2007	A1
20070021799	Kieval et al.	Jan 2007	A1
20070027388	Chou	Feb 2007	A1
20070027497	Parnis	Feb 2007	A1
20070038038	Stivoric et al.	Feb 2007	A1
20070038078	Osadchy	Feb 2007	A1
20070038255	Kieval et al.	Feb 2007	A1
20070038262	Kieval et al.	Feb 2007	A1
20070043301	Martinsen et al.	Feb 2007	A1
20070043303	Osypka et al.	Feb 2007	A1
20070048224	Howell et al.	Mar 2007	A1
20070060800	Drinan et al.	Mar 2007	A1
20070060802	Ghevondian et al.	Mar 2007	A1
20070073132	Vosch	Mar 2007	A1
20070073168	Zhang et al.	Mar 2007	A1
20070073181	Pu et al.	Mar 2007	A1
20070073361	Goren et al.	Mar 2007	A1
20070082189	Gillette	Apr 2007	A1
20070083092	Rippo et al.	Apr 2007	A1
20070092862	Gerber	Apr 2007	A1
20070104840	Singer	May 2007	A1
20070106132	Elhag et al.	May 2007	A1
20070106137	Baker, Jr. et al.	May 2007	A1
20070106167	Kinast	May 2007	A1
20070118039	Bodecker et al.	May 2007	A1
20070123756	Kitajima et al.	May 2007	A1
20070123903	Raymond et al.	May 2007	A1
20070123904	Stad et al.	May 2007	A1
20070129622	Bourget et al.	Jun 2007	A1
20070129643	Kwok et al.	Jun 2007	A1
20070129769	Bourget et al.	Jun 2007	A1
20070142715	Banet et al.	Jun 2007	A1
20070142732	Brockway et al.	Jun 2007	A1
20070149282	Lu et al.	Jun 2007	A1
20070150008	Jones et al.	Jun 2007	A1
20070150009	Kveen et al.	Jun 2007	A1
20070150029	Bourget et al.	Jun 2007	A1
20070162089	Mosesov	Jul 2007	A1
20070167753	Van Wyk et al.	Jul 2007	A1
20070167848	Kuo et al.	Jul 2007	A1
20070167849	Zhang et al.	Jul 2007	A1
20070167850	Russell et al.	Jul 2007	A1
20070172424	Roser	Jul 2007	A1
20070173705	Teller et al.	Jul 2007	A1
20070180047	Dong et al.	Aug 2007	A1
20070180140	Welch et al.	Aug 2007	A1
20070191723	Prystowsky et al.	Aug 2007	A1
20070207858	Breving	Sep 2007	A1
20070208233	Kovacs	Sep 2007	A1
20070208235	Besson et al.	Sep 2007	A1
20070208262	Kovacs	Sep 2007	A1
20070232867	Hansmann	Oct 2007	A1
20070249946	Kumar et al.	Oct 2007	A1
20070250121	Miesel et al.	Oct 2007	A1
20070255120	Rosnov	Nov 2007	A1
20070255153	Kumar et al.	Nov 2007	A1
20070255184	Shennib	Nov 2007	A1
20070255531	Drew	Nov 2007	A1
20070260133	Meyer	Nov 2007	A1
20070260155	Rapoport et al.	Nov 2007	A1
20070260289	Giftakis et al.	Nov 2007	A1
20070273504	Tran	Nov 2007	A1
20070276273	Watson, Jr.	Nov 2007	A1
20070282173	Wang et al.	Dec 2007	A1
20070299325	Farrell et al.	Dec 2007	A1
20080004499	Davis	Jan 2008	A1
20080004904	Tran	Jan 2008	A1
20080024293	Stylos	Jan 2008	A1
20080024294	Mazar	Jan 2008	A1
20080039700	Drinan et al.	Feb 2008	A1
20080120784	Warner et al.	Feb 2008	A1
20080058614	Banet et al.	Mar 2008	A1
20080059239	Gerst et al.	Mar 2008	A1
20080091089	Guillory et al.	Apr 2008	A1
20080114220	Banet et al.	May 2008	A1
20080139934	McMorrow et al.	Jun 2008	A1
20080146892	LeBoeuf et al.	Jun 2008	A1
20080167538	Teller et al.	Jul 2008	A1
20080171918	Teller et al.	Jul 2008	A1
20080171922	Teller et al.	Jul 2008	A1
20080171929	Katims	Jul 2008	A1
20080183052	Teller et al.	Jul 2008	A1
20080200774	Luo	Aug 2008	A1
20080214903	Orbach	Sep 2008	A1
20080220865	Hsu	Sep 2008	A1
20080221399	Zhou et al.	Sep 2008	A1
20080221402	Despotis	Sep 2008	A1
20080224852	Dicks et al.	Sep 2008	A1
20080228084	Bedard et al.	Sep 2008	A1
20080275465	Paul et al.	Nov 2008	A1
20080287751	Stivoric et al.	Nov 2008	A1
20080287752	Stroetz et al.	Nov 2008	A1
20080293491	Wu et al.	Nov 2008	A1
20080294019	Tran	Nov 2008	A1
20080294020	Sapounas	Nov 2008	A1
20080318681	Rofougaran et al.	Dec 2008	A1
20080319279	Ramsay et al.	Dec 2008	A1
20080319282	Tran	Dec 2008	A1
20080319290	Mao et al.	Dec 2008	A1
20090005016	Eng et al.	Jan 2009	A1
20090018410	Coene et al.	Jan 2009	A1
20090018456	Hung	Jan 2009	A1
20090048526	Aarts	Feb 2009	A1
20090054737	Magar et al.	Feb 2009	A1
20090062670	Sterling et al.	Mar 2009	A1
20090073991	Landrum et al.	Mar 2009	A1
20090076336	Mazar et al.	Mar 2009	A1
20090076340	Libbus et al.	Mar 2009	A1
20090076341	James et al.	Mar 2009	A1
20090076342	Amurthur et al.	Mar 2009	A1
20090076343	James et al.	Mar 2009	A1
20090076344	Libbus et al.	Mar 2009	A1
20090076345	Manicka et al.	Mar 2009	A1
20090076346	James et al.	Mar 2009	A1
20090076348	Manicka et al.	Mar 2009	A1
20090076349	Libbus et al.	Mar 2009	A1
20090076350	Bly et al.	Mar 2009	A1
20090076364	Libbus et al.	Mar 2009	A1
20090076397	Libbus et al.	Mar 2009	A1
20090076401	Mazar et al.	Mar 2009	A1
20090076405	Amurthur et al.	Mar 2009	A1
20090076410	Libbus et al.	Mar 2009	A1
20090076559	Libbus et al.	Mar 2009	A1
20090182204	Semler et al.	Jul 2009	A1
20090234410	Libbus et al.	Sep 2009	A1
20090292194	Libbus et al.	Nov 2009	A1
20100056881	Libbus et al.	Mar 2010	A1
20100191310	Bly et al.	Jul 2010	A1
20110144470	Mazar et al.	Jun 2011	A1

Foreign Referenced Citations (15)

Number	Date	Country
2003-220574	Oct 2003	AU
1487535	Dec 2004	EP
1579801	Sep 2005	EP
2005-521448	Jul 2005	JP
WO 0079255	Dec 2000	WO
WO 0189362	Nov 2001	WO
WO 02092101	Nov 2002	WO
WO 03082080	Oct 2003	WO
WO 2005051164	Jun 2005	WO
WO 2005104930	Nov 2005	WO
WO 2006008745	Jan 2006	WO
WO 2006102476	Sep 2006	WO
WO 2006111878	Nov 2006	WO
WO 2007041783	Apr 2007	WO
WO 2007106455	Sep 2007	WO

Related Publications (1)

	Number	Date	Country
	20090076363 A1	Mar 2009	US

Provisional Applications (4)

Number	Date	Country
60972537	Sep 2007	US
60972629	Sep 2007	US
61055666	May 2008	US
61055645	May 2008	US

Adherent device with multiple physiological sensors

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

US Classifications

Field of Search

US

International Classifications

Term Extension